Adenylate Kinase and AMP Signaling Networks: Metabolic Monitoring, Signal Communication and Body Energy Sensing

doi:10.3390/ijms10041729

Int J Mol Sci. 2009 April; 10(4): 1729–1772.

Published online 2009 April 17. doi: 10.3390/ijms10041729

PMCID: PMC2680645

Adenylate Kinase and AMP Signaling Networks: Metabolic Monitoring, Signal Communication and Body Energy Sensing

Petras Dzeja^* and Andre Terzic

Division of Cardiovascular Disease, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA; E-Mail: terzic.andre/at/mayo.edu (A.T.)

^* Author to whom correspondence should be addressed; E-mail: dzeja.petras/at/mayo.edu (P.D.)

Received March 9, 2009; Revised March 26, 2009; Accepted April 2, 2009.

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

This article has been cited by other articles in PMC.

Abstract

Adenylate kinase and downstream AMP signaling is an integrated metabolic monitoring system which reads the cellular energy state in order to tune and report signals to metabolic sensors. A network of adenylate kinase isoforms (AK1-AK7) are distributed throughout intracellular compartments, interstitial space and body fluids to regulate energetic and metabolic signaling circuits, securing efficient cell energy economy, signal communication and stress response. The dynamics of adenylate kinase-catalyzed phosphotransfer regulates multiple intracellular and extracellular energy-dependent and nucleotide signaling processes, including excitation-contraction coupling, hormone secretion, cell and ciliary motility, nuclear transport, energetics of cell cycle, DNA synthesis and repair, and developmental programming. Metabolomic analyses indicate that cellular, interstitial and blood AMP levels are potential metabolic signals associated with vital functions including body energy sensing, sleep, hibernation and food intake. Either low or excess AMP signaling has been linked to human disease such as diabetes, obesity and hypertrophic cardiomyopathy. Recent studies indicate that derangements in adenylate kinase-mediated energetic signaling due to mutations in AK1, AK2 or AK7 isoforms are associated with hemolytic anemia, reticular dysgenesis and ciliary dyskinesia. Moreover, hormonal, food and antidiabetic drug actions are frequently coupled to alterations of cellular AMP levels and associated signaling. Thus, by monitoring energy state and generating and distributing AMP metabolic signals adenylate kinase represents a unique hub within the cellular homeostatic network.

Keywords: Phosphotransfer enzymes, system bioenergetics, energy transfer, adenosine 5’-triphosphate, adenosine 5’-monophosphate, nucleotide metabolism, AMP-activated protein kinase, ATP-sensitive potassium channel

Contents

Introduction
Adenylate kinase isoform-based energetic and metabolic signaling network
- 2.1. Adenylate kinase isoforms in the nucleus
- 2.2. Adenylate kinase isoforms in cell motility and nucleotide pool homeostasis
- 2.3. Adenylate kinase localization and interacting partners
Adenylate kinase catalyzed β-phosphoryl transfer and cell energy economy
Adenylate kinase and AMP signaling: an integrated metabolic monitoring and signal ommunication system
AMP as universal fuel consumption and low energy signal, mediator of drug action and therapeutic agent
Adenylate kinase and AMP signaling networks in body energy sensing
Adenylate kinase never rests: from altered energetic signaling to immunodeficiency, cell motility defects, reticular dysgenesis and sensorineural deafness
Summary

1. Introduction

Recent studies provide new evidence of the unique energetic, metabolic monitoring and signaling role played by the ubiquitous enzyme adenylate kinase which catalyzes the nucleotide phosphoryl exchange reaction 2ADP ↔ ATP + AMP, critical in cell life [1–11]. Historically, the function of adenylate kinase has been ascribed to de novo adenine nucleotide synthesis and cell energy economy through regulation of nucleotide ratios in different intracellular compartments and AMP-sensitive metabolic enzymes [1,12–17]. Adenylate kinase has been intensely studied, including its genetics and gene polymorphism, tissue and developmental expression, intracellular distribution and structurefunction relationship [2,3,14,16–25]. This exemplifies adenylate kinase as a model protein for nucleotide binding folds and phosphoryl transfer catalysis [19,24,25]. The energetic role of adenylate kinase has gained particular significance following discovery that this enzyme facilitates transfer and utilization of γ- and β-phosphoryls in the ATP molecule through a chain of sequential reactions [1,26–28]. The adenylate kinase-catalyzed energy transfer shuttle and ligand conduction circuit concept [1,5,29–31] (Figure 1) is supported by biochemical, phosphoryl exchange measurements using ¹⁸Olabeling, physiological and gene-knockout studies [4,5,8,15,27–42], and is broadly used to explain energetic signaling mechanisms in heart and skeletal muscles [5,15,42–44], in hormone secretion [45–47], organ failure [4,31,48–50], tumor development [51–53], energy support of the cell nucleus [30,34,54,55], as well as in sperm and cell motility [8,56–59]. Muscles of AK1 knockout mice, with one less phosphotransfer chain, display lower energetic efficiency, slower relaxation kinetics and a faster drop in contractility upon ischemia associated with compromised myocardial-vascular crosstalk, AMP and adenosine generation, and impaired metabolic signal communication to the membrane metabolic sensor - the ATP-sensitive potassium channel (K-ATP) and distorted signaling to the energy-sensing AMP-activated protein kinase (AMPK) [4,5,1,32,33,35,39–42]. The unique ability of the ¹⁸O-assisted ³¹P-NMR technique to monitor adenylate kinase phosphotransfer and AMP signal dynamics in intact tissues, together with measurements of phosphotransfer rates through creatine kinase and glycolytic/glycogenolytic circuits and responses of metabolic sensors provide further insights into an integrated cellular energetic, metabolic monitoring and energy sensing interface [5,30,37,44,60].

Figure 1.

Adenylate kinase shuttle facilitates transfer of ATP β- and γ-phosphoryls from generation to utilization sites.

Due to a unique property of the catalyzed reaction, adenylate kinase is recognized as a sensitive reporter of the cellular energy state, translating small changes in the balance between ATP and ADP into relatively large changes in AMP concentration [1,2,5,29,62]. This enables enzymes and metabolic sensors that are affected by AMP to respond with higher sensitivity and fidelity to stress signals [33,35,42,52,60–63]. Recent data further indicate that adenylate kinase mediated intracellular AMP signaling is coupled with a number of AMP-responsive elements including metabolic sensors, AMPsensitive metabolic enzymes and adenosine signaling [5,30,33,42,47,61–65]. By catalyzing nucleotide exchange and AMP signaling, adenylate kinase regulates the activity of glycolytic and glycogenolytic enzymes and provides an integrative node for both pathways to respond rapidly to fluctuating energy demands [5,30]. Adenylate kinase generated AMP is emerging as a potential metabolic signal whose intracellular and circulatory levels determine the balance of peripheral organ energy supply between glucose, glycogen and fat, thus regulating food intake, hormonal state, sleep, hibernation and body energy sensing in conjunction with hypothalamic AMP-activated protein kinase (AMPK), K-ATP channels and adenosine metabolic signaling cascades [4,5,30,63–69]. Thus, such integrated energetic and metabolic signaling roles place adenylate kinase as a hub within the metabolic regulatory system coordinating components of the cellular bioenergetics network.

A distinct role for adenylate kinase is emerging in cell motility, differentiation and mechanoelectrical signal transduction. Adenylate kinase has been implicated in spermatozoa motility by facilitating ATP delivery from midpiece mitochondria to remote ATPases in the tail [20]. It was demonstrated that through interaction with anchoring protein Oda5p adenylate kinase provides local ATP for dynein ATPase, ensuring that both high-energy phosphate bonds of ATP are efficiently utilized at the major site of power production of the microtubule motors involved in diverse cellular movements [57,70]. A recent study has demonstrated that a mutation in adenylate kinase 7 (AK7) underlies a primary ciliary dyskinesia phenotype in chronic obstructive pulmonary disease [7]. Moreover, van Horssen et al. [8] demonstrated that cytoskeleton-based cell motility can be modulated by spatial repositioning of adenylate kinase 1 (AK1) enzymatic activity providing local ATP supply and ‘on-site’ fueling of the actomyosin-machinery. More significantly and unexpectedly, mutations in the mitochondrial AK2 (adenylate kinase 2) gene have been identified in individuals affected with reticular dysgenesis, the most severe form of inborn severe combined immunodeficiencies (SCID), which is associated with sensorineural deafness, a process where nucleotide signaling, cell motility and ciliary functions are involved [9,10]. Knockdown of zebra fish ak2 lead to aberrant leukocyte development, stressing the critical role of AK2, the major isoform in this type of cells, in leukocyte differentiation [10].

It is increasingly recognized that systemic integration of complementary energetic and metabolic signaling networks ensures cellular energy homeostasis and an adequate response to a broad range of functional activities and stress challenges [5,44]. A network and circuit view of the cellular energetic system allows for new perspectives leading to a comprehensive understanding of disease conditions associated with disturbances in energy metabolism, metabolic monitoring and signaling, and metabolic sensors response [5,71,72]. The purpose of this review is to summarize recent evidence regarding the role of the adenylate kinase phosphotransfer circuit in facilitating intracellular energetic communication, metabolic monitoring and AMP signal transduction. We highlight that due to intrinsic catalytic properties adenylate kinase is able to monitor and sense cell and body energetic imbalances caused by physical activity, inadequate oxygenation or nutrient supply. By generating and transmitting metabolic signals to a number of AMP/nucleotide-sensitive cellular and extracellular components, adenylate kinase is a primary player in adjusting cellular energetics, food intake, substrate transport and vascular blood flow to direct nutrient and oxygen delivery and maintain energy homeostasis.

2. Adenylate Kinase Isoform-Based Energetic and Metabolic Signaling Network

The existence of multiple isoforms of an enzyme usually relates to their different intracellular distribution and kinetic properties according to the local metabolic requirements (Figure 2) [8,13,14,51,56,57,73]. Following the discovery of adenylate kinase more than six decades ago [see 57], three major isoforms, AK1, AK2 and AK3 have been identified, which are localized in the cytosol, mitochondrial intermembrane space and matrix, respectively [13,14,73]. They differ in molecular weight, structure, kinetic properties and nucleotide specificity [19,25,74]. AK1 and AK2 specifically bind AMP and favor binding to ATP over other nucleotide triphosphates, while AK3 is a GTP:AMP phosphotransferase specific for the phosphorylation of intramitochondrial AMP, but can only use GTP or ITP as a substrate [13,75]. Within the AK family there are several conserved regions, including a P-loop, AMP- and MgATP/MgADP-binding domains and a lid domain [19,25]. Adenylate kinase isoforms can form dimers and higher molecular order structures [76,77]. Phosphorylation of adenylate kinase has not been detected; but acetylation and myristoylation, which could facilitate binding of adenylate kinase to cell membranes, mitochondria or the nucleus, have been demonstrated [56,73,78]. Recently discovered glutathionylation of adenylate kinase could confer regulation of its activity by the cellular redox state [79].

Figure 2.

Adenylate kinase isoform network and intracellular localization.

Different polymorphic subforms of AK1 (AK1-1 and AK1-2) and splice variants of AK2 (AK2AD) have been found, which have distinct electrophoretic mobility and kinetic properties, i.e. AK2A (26.5 kDa) and AK2B (25.6 kDa) [2,5,80,81]. AK1-2 occurs only in the Caucasian populations and is common among hemophilia-A patients [81]. A recent study indicates that the negative effect of smoke on birth weight is more marked in AK1-1 mothers that in AK1-2 carriers, suggesting that zygotes carrying AK1-2 allele are more protected from damaging factors [82]. Interestingly, the specific activity of AK1-2 is about 3.5-times lower than that of AK1-1, whereas the Michaelis constants do not differ for the allelozymes [80]. Sequence analysis showed that Glu-123 in AK1-1 is exchanged for Gln-123 in AK1-2. Mitochondrial AK2-1(A) subform was found in about 30% of bipolar manic depression syndrome (MDS) patients, but in no case of unipolar MDS or controls. Also, tissue specific adenylate kinase isoforms AK4 and AK5 have been cloned which have mitochondrial matrix and cytosolic localization respectively (Figure 2) [2,23]. AK4 protein levels are increased in cultured cells exposed to hypoxia and in animal models of neurodegenerative diseases [83]. Although AK4 is enzymatically inactive it retains nucleotide binding capability, interacts with the mitochondrial ADP/ATP translocator and serves stress responsive protein function promoting cell survival and proliferation [83]. Both AK4 and AK3 are among hypoxia-inducible factor 1 (HIF-1) regulated genes promoting cell survival [84,85]. AK5 was detected in human pancreatic beta-cells and was implicated in regulation of the K-ATP channel [47], while appearance of autoantibodies to AK5 in refractory limbic encephalitis patients carries a poor prognosis [86]. More recently, the existence of an additional AK1 gene product, the p53-inducible membrane-bound myristoylated AK1β, has been reported and implicated in p53-dependent cell-cycle arrest and nucleotide exchange in the submembrane space [51,73,87]. In this context, the gene encoding AK1 is down-regulated during tumor development, which could be associated with lower AK1β levels and cell cycle disturbances [88]. AK1β also has been demonstrated to be associated with the nuclear envelope [73] and proteomic studies have identified AK1β in epithelium microvilli [89], suggesting a role in energy support of nuclear and epithelia transport processes.

2.1. Adenylate kinase isoforms in the nucleus

The AK6 isoform was identified to be localized to the cell nucleus where energy provision and nucleotide channeling into DNA synthesis play a critical role in processing genetic information [34,54]. However, there is still controversy regarding the AK6 isoform which is also known as TAF9 RNA polymerase II possessing ATPase activity [90], suggesting that other adenylate kinase isoforms (AK1 and AK5) can also subserve nuclear energetic needs (Figure 2) [13,34,73]. Knockdown of AK6 slows growth and development of C. elegans [91], while in yeast a point mutation in Fap7 gene, an analog of AK6, reduces growth on glucose [92]. Another nuclear protein Rad50, a member of DNA repair RAD50/MRE11/NBS1 protein complex (RMN), which is essential for sensing and signaling from DNA double-strand breaks, in addition to ATP binding and hydrolysis bears an adenylate kinase activity required for efficient tethering between different DNA molecules [93]. A mutation affecting the adenylate kinase activity of Rad50, necessary for DNA tethering also abolishes the formation of viable spores [93]. Mutations in the genes that encode Nbs1 and Mre11, which are part of the RMN complex, are responsible for the human radiation sensitivity disorder, the Nijmegen breakage syndrome (NBS), and the ataxia-telangiectasia-like disorder (ATLD), which are characterized by defective checkpoint responses and high levels of chromosomal abnormalities [94]. Interestingly, the Nijmegen breakage syndrome gene product, Nbs1, is required for enzymatic activities of Rad50 and whole RMN complex function, including partial unwinding of a DNA duplex and efficient cleavage of fully paired hairpins [95]. Thus, adenylate kinase and adenylate kinase activity-possessing proteins play a significant role in the energetics of cell nucleus which is separated from major ATP generating processes in the cytosol.

2.2. Adenylate kinase isoforms in cell motility and nucleotide pool homeostasis

The large molecular weight isoform AK7 is associated with cell motility and other processes [5]. Recently, a high level of expression of the AK7 isoform has been demonstrated in bronchial epithelium and appears to be associated with ciliary function [96]. AK7 is a differentiation marker of kinocilia-bearing cells [97], and mutation in the AK7 gene is associated with human ciliary dyskinesia [7]. In this regard, Foxj1, a forkhead transcription factor necessary for ciliogenesis, induces adenylate kinase isoforms AK5 and AK7 along with genes whose products comprise dynein arms [98]. Yet to be named, a protein with adenylate kinase domains coded by chromosome 9 open reading frame 98 (C9orf98) gene is associated with cell migration and nucleotide exchange [99]. In this regard, sea urchin embryo cilia and sperm flagella use high-molecular weight adenylate kinase with triplicated catalytic domains to power swim by ciliary and flagellar movement [100]. Thus, multiple adenylate kinase isoforms create a phosphotransfer network to serve specific needs in different cellular compartments for energetic and metabolic signaling.

Heart muscle harbors about 30 – 40% of adenylate kinase activity in mitochondria particularly in the intermembrane space [26,74]. The mitochondrial AK2 isoform has the highest affinity (lowest Km) for AMP (≤ 10 μM) among AMP metabolizing enzymes and is highly concentrated in the narrow intermembrane space [18,26,74]. Virtually all the AMP reaching mitochondria is converted to ADP and channeled into oxidative phosphorylation maintaining a low cytosolic AMP concentration [21,35,41,101]. In such a way, adenylate kinase tunes cytosolic AMP signals and guards the cellular adenine nucleotide pool [1,41,102,103]. During intense physical activity or metabolic stress, such as ischemia, the AMP concentration rises, turning on other AMP-metabolizing enzymes such as AMPdeaminase and 5’-nucleotidase producing IMP and adenosine [60,104]. In this regard, a marked elevation of mitochondrial AK2 activity has been demonstrated in hypertrophy in response to increased energy demand and the necessity to maintain the cellular adenine nucleotide pool [105]. In Drosophila, AK2 is essential for survival and circadian rhythm formation and the lack of the AK2 gene causes significant insect growth suppression [2]. AK2 is downregulated in Keloids disease associated with fibroproliferative dermal tumors developing as a result of deregulated wound healing [106].

Expression of adenylate kinase isoforms increases in response to muscle exercise, hypoxia, and metabolic stress [107,108]. Also, muscle exercise performance correlates with adenylate kinase activity, signifying that this enzyme is an integral part of cellular energetic homeostasis [108]. In addition, a decreased expression and activity of AK1 has been found in a mouse model for muscular dystrophy (mdx mice) suggesting a direct relationship between lack of dystrophin and alteration of AK1 inducing energetic deficit [109]. A significant increase in AK1 in obese patients could indicate an imbalance in AMP signaling in this metabolic syndrome [110].

2.3. Adenylate kinase localization and interacting partners

Although major compartments for adenylate kinase isoform localization are known based on cellular fractionation, intimate intracellular anatomy of adenylate kinase distribution has only been studied by immunocytochemistry in neuronal cells and skeletal muscle [74,111,112]. In skeletal muscle myofibrils, adenylate kinase is localized in linear arrays along with creatine kinase and glycolytic enzymes [111]. Similar localization of GFP-tagged AK1 was detected in neonatal cardiomyocytes [76]. Such sequential arrangement of adenylate kinase molecules could provide a bidirectional phosphorelay that links ATP-generation with ATP-consumption and ATP-sensing processes [1,5]. Another study using tagged proteins indicates that AK1β-EGFP is mainly localized on the plasma membrane, whereas AK1-EGFP is distributed throughout the cell except for trace amounts in the nuclear membrane and some vesicles [87]. Adenylate kinase was found to co-purify and presumably interact with glycolytic enzymes and associate with myofibrils, cellular and mitochondrial membranes [21,26,33,51,73,74,78,113]. Adenylate kinase was also found to be engaged in intimate functional/structural interactions with the sarcolemmal K_ATP channel, a major metabolic sensor [33,46,47]. More recently, a phosphotransfer enzyme anchoring protein FHL2 was discovered in heart muscle [76]. This protein positions adenylate kinase and other phosphotransfer enzymes close to ATP utilization sites in myofibrils ensuring that both high-energy phosphate bonds of ATP are efficiently utilized. Mutation of the FHL2 protein is associated with cardiomyopathy [76]. Another adenylate kinase anchoring protein, Oda5p, anchors adenylate kinase in the proximity of the dynein arm ensuring that both high-energy phosphate bonds of ATP are efficiently utilized at the major site of power production of the microtubule motors involved in diverse cellular movements [57,70]. In epididymal spermatozoa adenylate kinase AK1 interacts with sperm associated protein P25b within cholesteroland sphingolipid-enriched membrane domains [114]. Such association and localization is necessary for peri-membrane space ATP homeostasis and for sperm maturation and fertilization [114].

A direct interaction between adenylate kinase and several enzymes of the dNTP synthase complex, as well as nucleoside diphosphate kinase was demonstrated using protein affinity chromatography and immunoprecipitation [115]. These results identified adenylate kinase as a specific component of the nuclear dNTP synthase complex, where it facilitates the survey of nucleotide ratios and the synthesis of nucleotides necessary for error-free DNA replication. Although topological positioning of specific proteins is crucial in energetics and signaling processes, the full interactome of adenylate kinase isoforms in cardiac muscle and other tissues is still unknown. In summary, molecular diversity and intracellular arrangement of adenylate kinase isoforms serve as a prototype of energetic and metabolic monitoring network where the localization of enzymes, their kinetic properties and the ability to communicate between different compartments play a critical role.

3. Adenylate Kinase Catalyzed β-Phosphoryl Transfer and Energy Economy

Adenylate kinase’s unique energetic function allows the utilization of the second high-energy bond of the β-phosphoryl in the ATP molecule, thereby doubling the energetic potential, a property not shared by other phosphotransfer systems [1,5,12,20,26,29]. This catalytic function of adenylate kinase is particularly important in tissues with high and fluctuating energy demands, as well as those under metabolic stress [1,2,5]. It is also important for the intimate energy supply to specific cellular processes such as cell ciliary, flagella or cytoskeleton based motility [8,20,29–31]. A concerted action of both cytosolic and mitochondrial adenylate kinase isoforms is required to facilitate high-energy phosphoryl delivery to cellular ATPases and feedback signal communication to mitochondrial respiration within structurally organized enzymatic modules and networks (see Figure 1) [1,26,29,31]. In these networks, a series of rapidly equilibrating reactions catalyzed by adenylate kinase provide the driving force for high-energy phosphoryl flux [1,5,30]. In addition, adenylate kinase coupled with creatine kinase and glycolytic pathways communicate adenine nucleotide flux changes generated by cellular ATPases to metabolic sensors [5,29,33,37]. In such a way phosphotransfer reactions synchronize electrical and mechanical activities with energy supply processes, which is fundamental for optimal function of the heart [44,116]. Adenylate kinase is one of principle components in the generation of metabolic oscillations by sustaining dynamic fluctuations of adenine nucleotide ratios [5,29,117,118]. In this regard, the term of excitable “adenylate kinase medium” has been proposed [119] to emphasize the significance of this enzyme in conveying energetic and metabolic signals [5,33]. These functions render adenylate kinase essential to the integrated cellular phosphotransfer network sustaining an efficient and vibrant cell energetic economy.

Further insights and key support for the current understanding of metabolic signaling networks in their full complexity have come with the development of new methodologies [1,4,15,31,44,60]. Highenergy phosphoryl fluxes through adenylate kinase, captured with ¹⁸O-assisted ³¹P-NMR, tightly correlated with the performance of the myocardium under various conditions of stress load [120]. This implicates that adenylate kinase along with other phosphotransfer reactions are indispensable routes that direct flow of high-energy phosphoryls between cellular ATPases and the ATP production machinery in mitochondria [44]. Labeling studies indicate that in intact tissues the highest adenylate kinase-catalyzed β-phosphoryl phosphotransfer flux is in the kidney, which approximates 98% of γ-ATP turnover, followed by the liver (80%), the heart (15 – 22%) and contracting (10 – 17%) or resting (3 – 5%) skeletal muscles suggesting an important role of adenylate kinase in tissue energy homeostasis [5,30,41]. Specifically, the total adenylate kinase enzymatic capacity measured in vitro in murine heart is about 6 mM/s, while the phosphotransfer flux in vivo is between 0.2–0.3 mM/s, it increases with functional load and can reach 1 mM/s in hypoxia and is expected to rise even more in ischemia [5]. For comparison, the range of phosphotransfer capacities of creatine kinase and glycolytic pathways are 6–10 mM/s and 2–3 mM/s, respectively [5]. In this regard, activities of adenylate kinase isoforms and intracellular free AMP levels tightly correlate with tissue respiration rates [16,121] and expression of adenylate kinase isoforms increases in response to muscle exercise, hypoxia, and metabolic stress [107,108]. Indeed, adenylate kinase remains active in its ATP regenerating and transferring role as long as ADP is available and the enzyme is not inhibited by a build-up of AMP [12,13]. Adenylate kinase phosphotransfer flux is markedly suppressed by high glucose in insulin secreting cells, reducing adenylate kinase-mediated AMP signaling to the K-ATP channel and AMPK, two key regulators of hormone secretion [45,122]. There is a reciprocal compensatory relationship between adenylate kinase and creatine kinase phosphotransfers to safeguard cellular energy economy: reduction of creatine kinase activity promotes high-energy phosphoryl transfer through the adenylate kinase system in creatine kinase-knockout muscles or under hypoxic stress [1,15,28,36,60].

The condensed mitochondrial structures and a very narrow intracristal space in the living cell poses diffusional limitations for nucleotide exchange [29]. Adenylate kinase (AK2) in the intermembrane space appears necessary to conduct the ADP stimulatory signal through the adenine nucleotide translocator to matrix ATP-synthases, as well as in exporting ATP produced by oxidative phosphorylation [2,21,29]. Disruption of the adenylate kinase gene impedes ATP export and mitochondria-cytosolic communication in yeast [101]. Muscles of AK1 knockout mice display lower energetic efficiency, slower relaxation kinetics and can not sustain low ADP levels under a functional load despite the presence of active creatine kinase, mitochondrial oxidative phosphorylation and glycolytic/glycogenolytic ATP-regenerating pathways, indicating disruption of the coherent energetic network with blunted response to metabolic signals [15,40–42]. Genetic disruption of both cytosolic M-CK- and AK1-catalysed phosphotransfer pathways compromises intracellular metabolic communication and energetic efficiency, reducing the cellular capability to maintain total ATP turnover under functional load [39]. These new methodologies and transgenic gene manipulations provide the opportunity to decipher regulatory mechanisms that underlie cardiac and skeletal muscle bioenergetic homeostasis.

Taken together, studies of adenylate kinase gene-knockout models have opened new perspectives for the further understanding of how cellular energetic and metabolic signaling networks integrate with genetic, biosynthetic, membrane-electrical and receptor-mediated signal transduction events [2,5,32,33,35,39]. Gene-knockout studies also revealed a remarkable plasticity of the cellular phosphotransfer system, where deficiency in an individual enzyme is compensated through the remodeling of the whole energetic network at enzymatic, architectural and genomic levels [15,36,123,124]. Unexpectedly and contrary to common beliefs that adenylate kinase promotes nucleotide degradation, the AK1 deficient heart had less ability to maintain nucleotide pools under metabolic stress [32,35]. Also, in failing hearts adenylate kinase activity tightly correlates with higher cellular adenine nucleotide content [49,50], indicating a new function for adenylate kinase to safeguard the cellular nucleotide pool by rephosphorylating AMP back to ADP and ATP.

Emphasizing the significance of intact energetic and metabolic signaling, AK1 deficiency is associated with a range of compensatory changes in glycolytic, glycogenolytic and mitochondrial metabolism and corresponding gene expression to support energy metabolism [4,15,32,35,39,123]. In this regard, one of the major finding resulting from adenylate kinase and creatine kinase knockout studies was the discovery that glycolytic/glycogenolytic enzymes have the ability to provide a network capacity for transferring and distributing high-energy phosphoryls [1,5,36]. The function of the adaptor protein DRAL/FHL-2, which anchors adenylate kinase, creatine kinase and glycolytic enzymes to sites of high energy consumption in myofibrils [76], further highlights the significance of the topological arrangement and integration of the intracellular phosphotransfer network in matching cellular energetic needs.

In summary, adenylate kinase-facilitated high energy phosphoryl transfer and coordination between cellular sites of ATP consumption and ATP generation are essential for the safeguard of the cellular nucleotide pool and energy economy. Although significant progress has been made, there are still significant unanswered questions concerning adenylate kinase physiology, especially regarding the energetic role of mitochondrial intermembrane AK2 and matrix AK3, nuclear AK6, ciliary AK7 and other tissue specific adenylate kinase isoforms.

4. Adenylate Kinase and AMP Signaling: An Integrated Metabolic Monitoring and Signal Communication System

Growing evidence indicates the significance of metabolic monitors which directly sense cellular energy state and respond to metabolic imbalances by generating and delivering signaling molecules to metabolic sensors and effectors to produce a regulatory response [1,2,5,52,62]. Central in metabolic monitoring is the enzyme adenylate kinase which constantly reads cellular adenine nucleotide balance, and, in case of disparity, generates AMP signals and facilitates their delivery to a number of AMPsensitive components, including those in the gycolytic and glycogenolytic pathways and to metabolic sensors and effectors such as K-ATP channels and AMPK, which adjust tissue energy and body hormonal state (Figure 3) [5,29,37,61]. Both K-ATP channels and AMPK can regulate cellular energy balance through managing Ca²⁺ influx and by phosphorylating targeted proteins [5,44]. Due to a unique property of the adenylate kinase-catalyzed reaction, a small decrease in ATP levels results in a large increase in AMP, making the latter a sensitive indicator and therefore a suitable signaling molecule of cellular energetic status [1,5,62]. In recent years AMP signaling is emerging as one of the most versatile system in the regulation of diverse cellular processes [5,72]. Importantly, AMP signals must be integrated and tuned to an appropriate level, since low or excess AMP signaling, due to metabolic, hormonal state or metabolic sensors mutations, are associated with disease conditions [5,29,37,61,62,72,125]. As a result of adenylate kinase-mediated metabolic monitoring and AMP signaling (Figure 3), the activity of ATP generating pathways is increased while ATP-consumption is decreased.

Figure 3.

Adenylate kinase metabolic monitoring system.

In particular, adenylate kinase phosphotransfer directly couples with K-ATP channels, facilitating the translation of metabolic signals critical in adjusting cellular excitability-dependent functions in response to demand [1,33,37,46,47,61]. In the intracellular environment where diffusion is restricted, reactions tend to depend strongly on the local rather than global concentrations of metabolites [37]. In this way, adenylate kinase-catalyzed AMP signal generation and nucleotide exchange in the intimate “sensing zone” of metabolic sensors regulate the dynamics and frequency of ligand switching in order to facilitate decoding of cellular information [5,30,44]. Indeed, intracellular measurements using the ¹⁸O-assisted ³¹P NMR and mass spectrometric techniques indicate that adenylate kinase is uniquely situated to tune the magnitude of the AMP signal because its phosphotransfer displays only a fraction of total capacity, is compartmentalized and not universally at equilibrium, thus it can differentially promote both AMP signal generation and AMP rephosphorylation [1,4,28,31,36,38,45,60,120,126]. In this way, adenylate kinase through negative and positive feedback loops governs adenine nucleotide and glycolytic oscillations providing a dynamic component for facilitated intracellular energetic signal communication [5,29,117,119]. Moreover, through a series of spatially linked enzymatic reactions adenylate kinase facilitates propagation of nucleotide signals in the intracellular and extracellular space, thus coordinating the response of metabolic sensors and nucleotide/nucleoside receptor signaling [1,5,64,65]. Therefore adenylate kinase provides sustained communication between cytosolic and nuclear processes coordinating cell energetic and genomic events [30,34] and between myocardium and vasculature regulating coronary flow and oxygen delivery [4].

Adenylate kinase-induced increase in AMP promotes the generation of adenosine, a powerful metabolic signaling and cardioprotective agent [60,104]. AMP also triggers AMPK activation, an essential signaling module in cellular adaptation to stress [42,52,62,127]. In the heart, the significance of AMPK is suggested by the findings that AMPK activity is increased in ischemia and preconditioning, and that AMPK agonists protect myocardium against ischemic injury [127,128]. Hypoxia or metabolic stress increases adenylate kinase flux inducing AMP generation and downstream AMP/adenosine signaling events important in cardioprotection [1,59,63,104]. Adenylate kinase deficiency compromises metabolic signal reception by metabolic sensors, such as K-ATP channels and AMPK producing a stress vulnerable phenotype [33,42]. In this regard, new data suggests that hydrolysis of AMP by CD73 on graft-resident or circulating cells regulates endothelial barrier function and diminishes transendothelial leukocyte trafficking and mitigates inflammatory and immune response of cardiac transplantation via the A(2B) adenosine receptors [129]. Thus, adenylate kinasemediated AMP signaling through metabolic sensors and nucleoside receptors is an integral part of cellular stress response system.

Adenylate kinase does not act alone in performing cellular metabolic monitoring. Recent evidence indicates that the interaction between adenylate kinase and creatine kinase phosphorelays determines metabolic signal communication to the K-ATP channel and mediates energetic remodeling in preconditioned and failing hearts [29,33,34,37,41,44,116]. Under normal conditions creatine kinase suppresses adenylate kinase phosphotransfer by scavenging cellular ADP [28] and thus maintaining the K-ATP channels in the closed state with low metabolic signaling through the AK → AMP → AMPK and AK → AMP → adenosine axis [33,52,61,105,116]. However, hypoxia or metabolic stress diminishes creatine kinase and increases adenylate kinase flux inducing AMP generation and downstream AMP/adenosine signaling events to adjust cellular energy balance [1,60,63,126]. Indeed, deletion of the AK1 gene shifts this balance towards the creatine kinase system, compromising energetic signal communication [4,33,35,39]. Accordingly, AK1 deficiency blunts metabolic signal reception by metabolic sensors, such as K-ATP channels and AMPK, compromising their ability to withstand energetic stress [33,42]. Underscoring the significance of phosphotransfer redistribution in metabolic signaling is the observation that altered adenylate kinase and creatine kinase phosphotransfer enzyme activities are associated with hypertrophy, abnormal vascular tone and hypertension [105,130,131].

The role of adenylate kinase in integrating signaling pathways is further indicated by the recent demonstration that AMP-stimulated AMPK regulates vascular response to hypoxia and nitric oxidedependent vasorelaxation as well as excitation of the oxygen-sensing carotid body which is critical for detection of O₂ deficit in the bloodstream and adjustment of breathing pattern [132–134]. In addition, adenylate kinase appears to be the major phosphotransfer system in extraocular muscle, where, together with creatine kinase, it regulates precise eye movements [135]. A more recent study suggests that intracellular and extracellular adenylate kinase plays an important role in nucleotide energetic signaling regulating actin assembly-disassembly involved in cell movement and chemotaxis [136]. Thus, the balance between phosphotransfer systems and subsequent signaling events determine the outcome of metabolic regulation of muscle contractility, electrical activity and vascular tone.

In recent years, adenylate kinase-mediated extracellular AMP and ADP signaling has gain an additional significance due to the involvement in high-density lipoprotein (HDL) endocytosis, in signaling through adenosine and AMP-specific receptors [137] and through AMP and other metabolite-sensing RNA riboswitches [138, 139], as well as in cell differentiation, tumor suppression and regulation of vascular tone [5,30,45,51,53,55,64,65,140,141]. In this regard, metabolic monitoring system in procaryotic cells utilizes RNA structures embedded at the 5′ ends of mRNAs to sense particular metabolic cues and regulate the encoded genes [142]. By sensing the energy status of muscle cells and regulating gene expression, the adenylate kinase and downstream AMP signaling are critical regulators of mitochondrial itochondrial biogenesis, through the AMPK-PGC-1 signaling cascade, thereby increasing the energy transducing capacity of the cell [138,143]. Moreover, adenylate kinase through AMP signaling regulates glycolytic and glycogenolytic pathways conveying information regarding increased energy demand [5]. Regulation of glycogen metabolism is of primary importance in muscle energetics, including that of the heart [5,144]. Particularly, defective AMP and AMPK signaling is a primary cause of imbalance in glycogen metabolism and associated disease conditions [145]. Adenylate kinase metabolic monitoring plays a significant role in plant tissues [146]. Modulation of plastidial adenylate kinase activity and consequently AMP and adenine nucleotide levels significantly increases starch yield and amino acid biosynthesis [147,148], while overexpression of adenylate kinase in yeasts markedly increases ATP production [149]. Thus, adenylate kinase by providing ATP β-phosphoryls for energetic needs and by regulating nucleotide ratios and AMP signaling adjusts the efficiency of energy metabolism, the capacity of ATP generating reactions and the activity of biosynthetic processes.

Intracellular energetic and metabolic signal communication can employ several different mechanisms ranging from facilitated diffusion to ligand conduction, depending on cell type and specific compartment, structural organization and topological arrangement of enzymatic networks [29,30]. While spatial heterogeneity and directionality of the enzyme-catalyzed process is not important in well mixed conditions in vitro, this becomes very important entity in highly organized living matter [150]. The cluster organization of enzymes and the high rate of unidirectional phosphoryl exchange in phosphotransfer systems would promote ligand conduction and signal communication at cellular distances [1,29,30]. Adenylate kinase facilitates mitochondria-nuclear energetic communication [34] and within the nucleus, embedded into organized enzymatic complexes of nucleotide-metabolizing and phosphotransfer enzymes, is involved in maintaining proper nuclear dNTP ratios and facilitates channeling of nucleotides into DNA replication machinery [115]. Imbalances in dNTP ratios affect the fidelity of DNA replication and repair leading to acquired mutations [30,115]. Thus, adenylate kinase surveys nucleotide ratios necessary for error-free DNA replication, while another nuclear protein Rad50, harboring adenylate kinase activity, participates in DNA double-strand break repair [93].

Despite recent advances in the metabolic signaling field, more studies are necessary to elucidate mechanisms which link adenylate kinase phosphotransfer flux, AMP signal dynamics and the response of metabolic sensors (AMPK, K-ATP), as well as the significance of AK → AMP → AMP-sensors signaling system in heart physiology, such as in shaping heart force-frequency relationship and Frank- Starling response, and cardioprotection [5,44]. At the molecular level, studies of multienzyme complexes including adenylate kinase would shed light on intimate mechanisms of metabolic sensing. Co-localization of components in signal transduction cascades is critical for the directionality and specificity of the signaling response. The presence of adenylate kinase in close proximity of AMPK would facilitate metabolic signal transduction and create a favorable energetic environment for the phosphorylation of targeted proteins. The significance and downstream mechanisms by which AK → AMP → AMPK signaling axis regulate cell cycle, developmental potential, and timing of differentiation are just starting to be elucidated. Thus, although more studies are needed, adenylate kinase-mediated metabolic monitoring and downstream AMP signaling is increasingly recognized among major homeostatic mechanisms in a number of cells, critical in the regulation of diverse cellular processes and stress-response.

5. AMP as Universal Fuel Consumption and Low Energy Signal, Mediator of Drug Action and Therapeutic Agent

Metabolic signals regulate and integrate many vital functions throughout the human body, including energy homeostasis, blood pressure, heart performance, food intake, hormonal status and brain performance [30,71]. Recent evidence suggests the general importance of adenylate kinase-mediated AMP signaling in appetite, wakefulness and sleep control and in hormonal, food and antidiabetic drug actions which are coupled to alterations of cellular AMP levels and associated signaling [4,5,46,47,55,62–70,86,138,151]. AMP signaling also plays an important role in hypoxic response, immune function and taste reception [60,85,129,137,139]. Adenylate kinase integrates and tunes AMP signals coming from different sources and delivers them to metabolic sensors to elicit a regulatory response (Figure 4). Reduced or increased adenylate kinase activity would distort integration of AMP signals and, depending on tissue metabolic phenotype and intensity of AMP-generating reactions, could produce both positive and negative impact on the activity of metabolic sensors [42,152].

Figure 4.

AMPing up and down — integration cellular AMP signals by adenylate kinase.

Recent evidence suggests that ingestion of fructose, a major constituent of sugar and high-fructose corn syrup, causes increase in cellular AMP and AMP/ATP ratio leading to activation of AMPK [68, 153]. Contrary to glucose, which usually lowers cellular AMP levels and inhibits AMPK, fructose activates hypothalamic AMPK and increases food consumption (Figure 4) [68]. Compared with glucose-sweetened beverages, consumption of fructose-sweetened beverages with meals elevates postprandial plasma triglycerides and lowers 24-h insulin and leptin profiles in normal weight women [154]. Fructose metabolism bypasses the rate-limiting step of the glucose pathway, and is metabolized much more quickly than glucose. Excessive fructose intake depletes cellular ATP by trapping inorganic phosphate required for ATP resynthesis, consequently inducing nucleotide degradation and increasing plasma uric acid and allantoin levels [155]. These metabolic alterations induced by fructose may play an important role in the epidemic of metabolic syndrome and may contribute the development of diabetes and cardiovascular disease [156]. A diet high in fructose can give rise to hyperlipidemia, insulin resistance and hypertension [157]. Similarly, ethanol consumption and subsequent acetate metabolism causes AMP accumulation in liver and other tissues resulting in increased AMP and adenosine signaling and blood flow [158,159]. Excess ethanol consumption can also cause nucleotide degradation and depletion of cellular adenine nucleotide pool [160]. However, short term and limited exposure to fructose and ethanol could be beneficial in stimulating energy metabolism and metabolic signaling, thus “AMPing” your body [153,161]. In this regard, cardioprotection induced by both fructose and ethanol preconditioning stimuli could be related to augmented AMP signaling [162,163].

Normal human blood AMP levels are in the 10–20 μM range of which only a fraction is free due to binding to serum proteins [164]. Intracellular and blood AMP levels are increased during physical activity and are sensitive indicators of myocardial ischemia rising within minutes after insult [165,166]. Adenylate kinase isoforms provide fine tuning of intracellular, interstitial and circulating AMP levels due to different kinetic properties and localization (Figure 5). Deficiency of AK1 isoform reduces the AMP signal stress response [4,32,33,35,42], however at the basal level it could result in higher AMP signaling due to compromised tune-up mechanisms [152]. Circulating AMP is emerging as a molecular mediator of hibernation and constant darkness effect, switching mice from a glucoseburning, fat-storing state to a fat-burning, glucose-conserving lethargy [66]. In hibernating mammals AMP originating, at least partly, from the brown fat also down-regulates the seasonally-dependent proliferation of the thymus [167]. In addition, overworked brains release adenosine, usually originating from AMP, to slow cell activity and trigger sleep [168,169]. These data strongly support the notion that AMP and adenosine play a key role as endogenous modulators of wakefulness and sleep which fits with our proposed role of phosphotransfer reactions in regulating brain activity and information processing [30].

Figure 5.

Regulation of intracellular AMP levels.

Available evidence suggests that growth factors, which alter cellular energy metabolism, and hormones, such as adipocyte-derived leptin and adiponectin, activate AMPK through local or temporal regulation of AMP levels [170–172]. Leptin alters muscle adenine nucleotide homeostasis (decreases ATP) and increases AMP dynamics (inferred from elevated AMP and IMP levels) followed by activation of AMPK [173–175]. This could be also due to increased expression of uncoupling proteins (UCP) - mitochondrial carriers that dissipate the electrochemical gradient across the mitochondrial inner membrane [176,177]. Mild uncoupling of mitochondria shift cellular nucleotide balance and, due to the monitoring function of adenylate kinase, AMP levels would go up triggering metabolic signaling cascades [176,177]. Interestingly, AMP by itself through interaction with ANT can produce uncoupling that could facilitate respiration and reduce ROS production [178], which could be beneficial during ischemia reperfusion.

AMP signaling plays a significant role in cellular senescence. It’s been shown by proteome analysis that AK1 protein is markedly increased in senescent skeletal muscle fibers [179] and that lifespan of worms can be extended by the addition of copies of the AMPK gene and by chronic activation of AMPK as is seen on calorie-restricted diets [180]. Indeed, AMP/ATP ratios are several folds higher in senescent fibroblasts compared with young fibroblasts and this is accompanied by a marked elevation in AMPK activity [181,182]. This could be viewed as a compensatory measure to cope with declining capacity of energy metabolism during aging. AMP and AMPK signaling is critical in cell differentiation, maintaining cell polarity and completing normal cell division as well as in induction of meiotic maturation in mammalian oocytes [183–185]. AMP directly or through AMPK plays a physiological role in modulating activity of cystic fibrosis transmembrane conductance regulator (CFTR) in polarized epithelia cells [186,187]. CFTP nucleotide binding folds possess an intrinsic adenylate kinase activity which could facilitate metabolic signal reception [61,188]. Thus, AMP signaling plays a critical role in altered hormonal and energetic states including cell differentiation, maintenance of polarity and senescence.

AMP is important mediator of insulin and metabolic protein kinase Akt signaling. It has been proposed that protein kinase Akt mediates inhibitory effects of insulin on AMPK [189]. Since Akt does not directly phosphorylate AMPK, changes in Akt activity induced by insulin can regulate AMPK through changes in cellular AMP/ATP ratio. Indeed, it was demonstrated that Akt activation reduces cellular AMP/ATP ratio causing decline in AMPK activity [190]. Insulin and Akt-mediated inhibition of AMPK can be overcome by metformin, which is known to act on site I of mitochondrial respiratory chain causing increase in AMP levels [189,191]. In this regard, free fatty acids, which activation generates AMP, prevents AMPK inhibition by insulin [192]. Thus, insulin-Akt signaling axis can expand the range of metabolic effects through tuning up AMP signals and the activity of AMPK.

Most importantly, recent studies indicate that pharmacological actions of popular antidiabetic drugs metformin and thiazolidinediones and cholesterol lowering statins are related to their ability to alter cellular AMP levels and consequently AMPK activity [151,193–195]. Time course studies revealed that troglitazone-induced increases in phosphorylated forms of AMPK and ACC are paralleled by an increase in the AMP-to-ATP ratio [193]. A similar increase in AMP is seen following incubation of cells with rosiglitazone [196]. Moreover, livers of rats treated with resveratrol, a constituent of red grapes and red wine, show a strong tendency for AMPK activation, as well as increase phosphorylation of two downstream indicators of its activity [197]. Besides inhibiting HMG-CoA reductase, statins preserve CD39/ATPDase activity in thrombin-treated endothelial cells [198]. Preservation of adenine nucleotide metabolism may directly contribute to the observed anti-thrombotic and anti-inflammatory actions of statins. In this regard, metformin, a biguanidine compound from French lilac and more recently extracts from bitter melon, a traditional Chinese medicine, activate AMPK and exerts its glucose lowering effect through mild interference with the efficiency of energy metabolism resulting in changes in intracellular nucleotide dynamics and AMP levels [151,194,199]. Through activating AMP signaling metformin also improves cardiac function after ischemia in rats [200, 201]. Interestingly that metformin increases glucose utilization and lactate production in cells with a dominant-negative mutant form of AMPK (DN-AMPK) [202], suggesting existence of AMPKindependent pathways of metabolic signaling including direct effects of AMP on other metabolic sensors and enzymes of energetic pathways.

Recent interest in clinical use of adenosine as “adenosine flush” and in reperfusion therapy is also associated with AMP signaling, activation of AMPK and replenishment of cellular ATP levels [203–205]. Adenosine, besides signaling through adenosine receptors, can be taken up by cells and phosphorylated to AMP initiating metabolic signaling cascades [104,206]. Subsequent conversion of AMP to ADP and ATP by reactions involving adenylate kinase and ATP synthesis in mitochondrial oxidative phosphorylation and glycolysis would replenish cellular ATP and total adenine nucleotide pool which is diminished during ischemic insult [104,206]. Thus, adenosine and AMP have pleiotropic metabolic signaling and energetic effects which could be further explored in reperfusion therapy.

Last but not least, AMP through interaction with taste receptors has the bitterness-suppressing quality that allows taste buds to interpret food as seeming “sweeter” [207]. This makes lower-calorie food products more palatable. Recently AMP has been approved by the FDA as a ‘Bitter Blocker’ additive to foodstuffs (Linguagen Corp.). AMP is found in a wide range of natural foods — including breast milk. Calcium compounds in breast milk are usually bitter and thus breast milk may be natural system using bitter-blockers. AMP also inhibits behavioral and electrophysiological responses of mice to bitter tastants [207]. A number of AMP containing medications are used for nutritional supplementation and for treating dietary shortage or imbalance and disease conditions [208]. Nucleotides such as AMP affect a number of immune functions, including the reversal of malnutrition and starvation-induced immunosuppression due to adenine nucleotide shortage, the enhancement of Tcell maturation and function and natural killer cell activity [208]. However AMP by itself has immunosuppressive properties. In fact, mosquito and fly saliva contains AMP and adenosine as vasodilatative agents which also have immunosuppressant activity facilitating pathogen or parasite transmission [209]. To this end, secreted and cell associated adenylate kinase has been identified as a virulence factor in a number of pathogens affecting nucleotide signaling and host immune defense [210]. Due to immunomodulatory function, a promising therapeutic potential for the AMP analog AICAR/(ZMP) exist in the treatment of multiple sclerosis and other Th1 cell-mediated inflammatory diseases such as psoriasis and arthritis [211]. Thus, AMP is emerging as pivotal metabolic signal conveying information about food consumption, hormonal and energy metabolism status, a regulator of brain activity associated with wakefulness and appetite control as well as a mediator of drug action and therapeutic agent.

6. Adenylate Kinase and AMP Signaling Networks in Body Energy Sensing

Sensing body energy level and corresponding mental and physical strength is important for humans and animals and this property had key survival and evolutionary advantages [5,30,72,212–216]. Here we further advance the hypothesis that body energy sensing is mediated in part by adenylate kinase, which conveys information about the adenine nucleotide pool status and, thus the overall energy balance [5,30]. The general concept has been proposed previously by H. Teagtmeyer [217] that systemic metabolic communication and energy transfer arises from the interaction of a series of moiety conserved cycles operating through tissues and circulation.

Phosphotransfer reactions have emerged as principle signal generators and coupling relays between cellular metabolism and metabolic sensors [5,29,30,44,218]. In particular, adenylate kinase as generator and modulator of metabolic signals is a critical player integrating complex AMPK and KATP channel signaling cascades in regulation of hormone secretion, blood flow, stress response, muscle and brain functional activity [1,4,5,30,33,34,37,47]. A case in point is myocardial-vascular metabolic signal communication governed by phosphotransfer redistribution, metabolic cycles and relays culminating in a metabolic sensor and functional response (Figure 6) [4]. As brain function specifically depends on glucose metabolism, new spatial and network representation of glycolytic pathway [5] allow for new perspectives and understanding of energetic signal communication and glucose sensing in neurons [30,212].

Figure 6.

Myocardial-vascular metabolic signaling as a paradigm of global energy sensing.

Body energy sensing depends on information relayed and distributed to a central network of metabolic sensing neurons through hard-wired neural connections and by metabolic and hormonal signals from the periphery coming through the blood and interstitial fluids [212,214]. The brain has a specialized set of neurons that integrate many of these signals and produce regulatory response. These, first described as “glucose sensing” neurons, are really broad-range cellular metabolic sensors that have transporters, metabolite-sensing kinases, ion channels, and receptors that allow them to sense and interpret signals coming from the periphery [214].

Metabolic sensing neurons are integrated into a network that links them to afferent and efferent pathways involved in the control of energy homeostasis [212]. Recent studies indicate that beside satiety hormonal signals, such as leptin and insulin, a myriad of metabolic inputs are generated and sensed by the brain including glucose, fructose, fatty acids and their metabolites, amino acids, Krebs cycle intermediates and nucleotides through specialized receptors and signaling cascades [212–216]. In many cases, reception or metabolism of these signals by sensing neurons results in altered intracellular ATP/AMP ratio and behavior of metabolic sensors such as AMPK, K-ATP channels and other regulators of firing activity [33,72,213,219,220]. This integrated information is then used not only to guide choices the animal makes about the amount of fuels to take in from the environment but also how stored fuels should be distributed and metabolized by various peripheral tissues. Molecular defects or a raise in threshold for sensing catabolic signals from the periphery by specialized metabolic sensing neurons is one of the causes of obesity [212–214].

Metabolism sensing neurons are regulated by glucose through mechanisms requiring either the KATP channel or the Na⁺/glucose cotransporter SGLT3, which is a glucose-sensing rather than glucosetransporting molecule [212–216]. In glucose-excited neurons, the decrease in ATP and ATP-to-ADP ratio leads to activation of K-ATP channels and plasma membrane hyperpolarization, and thus reduction in neuronal firing activity. In glucose-inhibited neurons, the reduced ATP-to-ADP ratio induces closure of chloride channels and/or reduction in the activity of the Na-K pump, depolarization of the plasma membrane, activation of voltage-sensitive Ca²⁺ channels, and synaptic neurotransmitter secretion. Changes in energy expenditure are achieved by regulating hormonal status, sympathetically mediated thermogenesis and cellular energy sensors such as AMPK, which switch off ATP-consuming and activate ATP-regenerating pathways in response to cellular fuel shortage [212–214]. Recent studies show that activity of AMPK is increased in the brain in response to low levels of cellular fuels and negative energy balance and, contrary to peripheral tissues, decreased by leptin [72,213,219]. Furthermore, reduced activity of AMPK in the hypothalamus reduces food intake and body weight [213,219]. Circulating leptin levels give the brain input regarding energy storage so it can regulate appetite and metabolism. Although leptin is a circulating signal that reduces appetite, in general, obese people have an unusually high circulating concentration of leptin and develop leptin resistance [212–214]. Among other factors, consumption of high amounts of fructose causes leptin resistance [221]. This could be due to excess of AMP signaling in the periphery induced by both leptin and fructose which is conveyed to the brain as false “low energy” signal forcing it to increase food consumption. AMP and other peripheral metabolic signals apparently can overcome inhibitory leptin signaling circuits in the hypothalamus [68,153,175]. In this regard, a significant increase in adenylate kinase isoform AK1 and other phosphotransfer enzymes in obese/overweight and morbidly obese women further indicate an imbalance in metabolic signaling in this metabolic syndrome [116].

Labeling studies of adenine nucleotide -phosphoryls indicate that adenylate kinase is active in the brain and that its phosphotransfer rate is increased by drugs improving cerebral circulation and memory dysfunction [222]. Similarly, photic stimulation increases adenylate kinase-mediated ATP β-phosphoryl turnover in photoreceptors suggesting a role in energetics of these specialized cells [223]. Other studies indicate that adenylate kinase isoforms in the brain may contribute to neuronal maturation and regeneration [23,224]. Activation of melanocortin system, which is involved in regulation of appetite, metabolism and body weight, increases expression of adenylate kinase AK1 in the hypothalamus [225]. AMPK, a master metabolic sensor present in hypothalamus, responds to adenylate kinase integrated AMP levels, and plays a critical role in hormonal and nutrient-derived anorexigenic and orexigenic signaling [62,72,226]. Adenylate kinase AK2 is among 14 genes mapped in quantitative trait loci for body weight and abdominal fat weight [227]. Recent proteome studies revealed that adenylate kinase AK2 may be an important regulator involved in the anti-lipid and antioxidant effects of tomato paste [228]. The down-regulation of AK1 expression by hyperglycemia in pancreas may contribute to the defective coupling of glucose metabolism to K-ATP channel activity in type 2 diabetes [48].

Information processing in the brain and energy sensing takes place not only intracellularly but also on extracellular surfaces and between different type of cells through intercellular connections [30,229,230]. In fact, brain ecto-adenylate kinase is an integral part of synaptosomal ATPmetabolizing enzyme cascades regulating ATP, AMP and adenosine signaling [231]. Similarly, adenylate kinase by regulating nucleotide exchange and signaling at peripheral nerve endings can convey information regarding the energy state of particular tissues, thus contributing to body energy sensing. In other cell types ecto-adenylate kinase provides a mechanism for propagation of nucleotide based signals along the cellular surface, thus coordinating multiple receptor-mediated signaling events [64,65]. Extracellular AMP induces bronchoconstriction in suspected asthmatic patients and is used in disease diagnostics as a bronchial provocation test [232]. Both ATP and adenosine signaling which could be modulated by adenylate kinase are critical in synaptic transmission and for normal brain function [233]. Thus, the systemic adenylate kinase → AMP → AMPK signaling network represents a new modality in body energy balance.

In different tissues, adenylate kinase activity depends on the nutritional and hormonal state [234,235]. Adenylate kinase phosphotransfer flux is markedly suppressed by high glucose in insulin secreting cells, reducing adenylate kinase-mediated AMP signaling to the K-ATP channel and AMPK, two regulators of hormone secretion [45,122]. In humans, deficiency of the AK1 isoform is associated with mental retardation, psychomotor impairment and congenital anemia [236]. In this regard, a strong correlation has been observed between fasting and higher expression of the adenylate kinase AK3 isoform, UCP3 and increased activity of AMPK and fatty acid oxidation [237], suggesting an interrelated signaling cascade. Although the significance of energetic and metabolic signaling is growing, little is known regarding the regulation of adenylate kinase phosphotransfer under different metabolic, hormonal and functional states, and how such regulation affects the ability of the cell to generate and respond to energetic stress-related signals.

A new emerging modality in extracellular and intracellular nucleotide signaling and information processing is the cAMP → AMP → adenosine/AMPK pathway sequentially connecting cAMP- and AMP-response elements [238]. In this pathway, cAMP signaling is followed by conversion of cAMP by phosphodiesterases to AMP that activates the AMP-signaling cascade [183]. The role of adenylate kinase in this system is envisioned to propagate AMP metabolic signals along the membrane surface or within the cytosolic space and nuclear compartment where AMPK resides [1,5,65,239]. Cosequently, production of adenosine from AMP by 5′-nucleotidase could stimulate adenosinergic signaling pathways [240]. Thus, this kind of integration of cyclic nucleotide → nucleotide → nucleoside signaling provides means of coordinating diverse signaling events and facilitating information transfer from one subsystem to another.

Understanding principles governing integration and synchronization of metabolic sensors with cellular metabolism is important for regulation of cellular energetic and ionic homeostasis as well as hormonal balance and food intake [37,61,241–243]. Growing evidence and increasing number of discovered metabolic signaling cascades indicate that these systems are essential in vital cellular processes integrating gene expression, metabolism and response to stress, moreover their defects are associated with diseases under a wide umbrella of “metabolic syndrome” [33,62,243,244]. In this regard, recent studies indicate that metabolites linked to glucose such as succinate and alphaketoglutarate can signal through specific G-protein-coupled receptors which are also present in neurons [245,246]. Glucose usually decreases adenylate kinase phosphotransfer flux and intracellular AMP levels and consequently adenosine signaling, but it can increase Krebs cycle substrate levels through anaplerosis [1,246]. Succinate and alpha-ketoglutarate also have signaling function in cell nucleus regulating DNA methylation, which has been implicated in obesity [247]. Taken together, emerging data indicate that coupling of “energetic” phosphotransfer enzymes with phosphoryltransfering protein kinase cascades and metabolite sensitive ion channels, transporters and receptors, comprise a unified intracellular and transcellular energetic and metabolic signal transduction matrix capable of processing, integrating and delivering cellular information regarding energy state (see Figure 6). Within this network, adenylate kinase and AMP signaling throughout the intracellular compartments, extracellular space and body fluids comprise a major metabolic monitoring and body energy sensing node, capable of transducing and distributing signals to metabolic sensors to adjust energy metabolism, fuel selection, food intake and functional response.

7. Adenylate Kinase Never Rests: From Altered Energetic Signaling to Immunodeficiency, Cell Motility Defects, Reticular Dysgenesis and Sensorineural Deafness

A thoughtful notion that “adenylate kinase never rests” was expressed by P.B. Detwiler more than a decade ago when commenting on the paper entitled “Adenine nucleoside diphosphates block adaptation of mechano-electrical transduction in hair cells” [248]. In this paper P.G. Gillespie and A.J. Hudspeth demonstrated that mechano-electrical signal transduction and adaptation by hair cells depends on adenine nucleotides and adenylate kinase reaction [248]. Indeed, the past decade further revealed that the dynamic behavior of the adenylate kinase reaction governs many intracellular and extracellular nucleotide signaling processes and that adenylate kinase mutations cause severe human disease phenotypes [1,2,8–11,22,30,102].

Adenylate kinase in conjunction with other phosphotransfer rections is involved in metabolic signaling to membrane ion channels regulating cell ionic balance and electrical activity, and in energy supply to distant ATPases powering spermatozoa and other cell motility related processes [20,29,31,33,44,47]. The large molecular weight isoform AK7 is unusual in the adenylate kinase family; it contains a Dpy-30 motif involved in protein dimerization and is associated with cell motility and other processes [2,5,96]. Mutations in the evolutionarily conserved Ak7 gene results in animals presenting with pathological signs characteristic of primary ciliary dyskinesia (PCD), including ultrastructural ciliary defects and decreased ciliary beat frequency in respiratory epithelium [7]. Ak7 appears to be a marker for cilia with (9 + 2) microtubular organization critical in motility, morphogenesis, cell division and immune response [7,97]. In humans PCD is a genetically and phenotypically heterogeneous disorder, characterized by progressive development of bronchiectasis, inflammation, and features characteristic of chronic obstructive pulmonary disease [7]. Thus, these results suggest that mutations of the human Ak7 gene may underlie a subset of genetically uncharacterized PCD cases.

More recently, the elegant work from B. Wieringa’s laboratory examining the adenylate kinase spatial positioning within a cell by utilizing different artificial location tags, demonstrate that cytoskeleton-based cell motility can be modulated by spatial repositioning of adenylate kinase enzymatic activity to provide local ATP supply and ADP scavenging capacity [8]. These results are corroborated by the use of another heterodimer-inducing approach for transient translocation of AK1 to the specific cellular sites under conditions of constant global AK1 activity in the cell [8]. Thus, adenylate kinase functions as a coupling factor between local ATP supply and regulation of actomyosin and other molecular motor behavior, which is central to cell shape changes and cell motility. Similarly, creatine kinase–mediated ATP supply fuels actin-based events in phagocytosis and is required for thrombin receptor signaling to the cytoskeleton [249,250]. In this regard, the dynamics of actin and myosin in brain presynaptic and postsynaptic regions play a critical role in brain activity and memory formation, and consume the major fraction of the total energy in neurons [251,252]. It remains to be determined whether adenylate kinase provides energy support for motor proteins involved in neuronal trafficking and memory consolidation. Interestingly in humans, genetic adenylate kinase deficiency or losses of adenylate kinase from the brain after surgery are associated with compromise intellectual function [253,254].

Conversion of mechanical stimuli to electrical signals in stereocilia of inner ear hair cells is associated with Ca²⁺ dynamics and movement of myosin motors, similar to many mechanoelectrical and ciliary motility systems [7,248]. The energy supply and nucleotide-based signaling coordinating behavior of such systems is provided by phosphotransfer enzymes including adenylate kinase [1,8,29,30]. It was demonstrated that the creatine kinase circuit is essential for high-sensitivity hearing as demonstrated by hearing loss in creatine kinase knockout mice [255]. Recently biallelic mutations in mitochondrial adenylate kinase AK2 gene have been identified in individuals affected with reticular dysgenesis [9]. Human reticular dysgenesis is the most severe form of inborn severe combined immunodeficiencies (SCID) associated with sensorineural deafness. This disease is characterized by the absence of granulocytes and almost complete deficiency of lymphocytes in peripheral blood. Mutations in AK2 gene result in absent or strong decrease in AK2 protein expression [9]. Restoration of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted set of hematopoietic lineages. Moreover, AK2 is specifically expressed in the stria vascularis region of the inner ear, which may provide an explanation of the sensorineural deafness in these individuals [9]. Interestingly, immunohistochemistry indicate that AK2 is present within the lumen of the stria vascularis capillaries suggesting that it could be functioning as an ecto-enzyme, however more detailed studies at the cellular level are required and different AK2 and other AK isoform antibodies should be tested. Since almost all cells contain mitochondria and intermembrane AK2, the negative result of intracellular AK2 immunohistochemistry could be related to inaccessibility of intermembrane proteins to antibodies.

It is known that ecto-adenylate kinase plays an important role in extracellular nucleotide signaling; however it is unusual to detect a mitochondrial isoform outside the cell [64,65]. An intriguing possibility exist that beside nucleotide signaling, mucosa embedded AK2 has specific mechanometabolic signal transduction functions and behavior similar to that described in smart hydrogels containing adenylate kinase [256]. A recent proteome study indicates adenylate kinase is present in the extracellular mucus [257]. However, whether the adenylate kinase system due to mutation of AK2 is altered in primary mechanoelectrical signal transducing hair cells which have abundant mitochondria should be determined. Our data indicate that both AK1 and AK2 associate with mitotic spindle, which have microtubular organization (9 + 2) similar to cilia, apparently to power cell division cycle and chromosome disjunction. Previous studies have shown that disruption of analogous adenylate kinase Aky2 gene in yeast coding mitochondrial intermembrane and partially cytosolic AKY2 protein halts ATP export from mitochondria [99]. Thus, AK2 isoform, usually confined within mitochondrial intermembrane space, may have important extramitochondrial functions.

That the gene encoding the mitochondrial energy metabolism related enzyme adenylate kinase 2 (AK2) is mutated in individuals with reticular dysgenesis is supported by simultaneously published independent evidence [10]. Knockdown of zebrafish ak2 gene leads to aberrant leukocyte development, stressing the evolutionarily conserved role of AK2 in leukocyte differentiation [10]. Mononuclear cells obtained from bone marrow of healthy donors lacked AK1, whereas AK2 was readily detectable. These results indicate that leukocytes may be susceptible to defects caused by the lack of AK2, as they do not express AK1 in sufficient amounts to compensate for AK2 functional deficits. Previous studies have linked AK1 mutations to severe nonspherocytic hemolytic anemia and associated with mental retardation and psychomotor impairment [3,236]. In this regard, the deficiency of another metabolic enzyme adenosine deaminase (ADA) accounts for approximately 17% of all SCIDs and 50% of all autosomal recessive SCIDs [258]. The metabolic basis of this immunodeficiency is likely related to accumulation of the ADA substrates adenosine and 2′-deoxyadenosine that kill T and B cells through mechanisms involving accumulation of dATP and induction of apoptosis [258]. Whether nucleotide metabolism is altered in AK2 mutant cells remains to be determined. Taken together, these observations suggest that reticular dysgenesis is the first example of a human immunodeficiency syndrome that is causally linked to the defective phosphotransfer enzyme involved in nucleotide signaling and mitochondrial energy metabolism.

In this regard, absence or reduction of AK2 protein would interfere with mitochondrial bioenergetics and mitochondria-nucleus energetic signal communication that could compromise implementation of leukocyte developmental program [9,30,34]. Evolvement of mitochondrial network and establishment of metabolic circuits are part of developmental programming and execution of cell differentiation sequences [259,260]. A recent study indicates that energy demand signaling gradients arising in the cell would allow propagation of information on local energy consumption over distances, through nucleotide-based signaling conveying positional information to mitochondria [261]. In such way, responding to energy demand gradients, mitochondria can pattern the cytoplasm over length scales that are suited to provide an energy supply continuum and convey morphogenetic information in large cells and tissues [259,261]. Thus, AK2 deficiency can disrupt the flow of developmental information governing cell differentiation.

Adenylate kinase supports energetics and motility of flagella containing parasites and secreted adenylate kinase is a major virulence factor in a number of pathogenic bacteria [5,20,56,57,210]. Recently, a novel myristoylated AK2 isoform has been discovered in P. falciparum causing severe tropical malaria [11]. This modification significantly enhances the stability of the kinase and apparently could be used for targeting the enzyme to membranes or other specific cellular sites, similar to AK1, another myristoylated adenylate kinase isoform [11,51]. The association of myristoylated AK2 with the disease causing clone could be used as a therapeutic target to fight malaria. A large specialized network of six adenylate kinase isoforms exists in a unicellular flagellated parasite Trypanosoma cruzi, the causative agent of Chagas’ disease [59]. This parasite apparently has developed a sophisticated phosphotransfer network where adenylate kinase acts in concert with arginine kinase and nucleoside diphosphate kinase to support the invasive phenotype [262]. Importantly, that mutation in the adenylate kinase gene renders pathogens avirulent [210], suggesting new ways to “silence” otherwise deadly bacteria. Also, a nonstructural protein 4B (NS4B) from hepatitis C virus, which is absolutely required for viral propagation, was found to possess adenylate kinase-like activity [263]. Adenylate kinase 2 is highly upregulated by INF-alpha and IL-15 stimulation in natural killer (NK) cells suggesting role in innate immune defense [264]. In this regard, due to unique catalytic properties and stability adenylate kinase is used as an enzyme amplification system in ATP biosensors for detecting bacterial contaminations in food industry, defense and health care that improves sensitivity levels up to several thousands fold (Celsis, AKuScreen). A recent study demonstrates that mitochondrial AK2 is directly involved in induction of apoptosis through the formation of an AK2-FADD-caspase-10 complex and that downregulation of AK2 attenuates etoposide- or staurosporine-induced apoptosis in human cells [6]. Significantly, that downregulation of cytosolic AK1 transcription with siRNA increases apoptosis in pancreatic cancer cells [265]. Thus, adenylate kinase plays a significant role in making decision between life and death in cellular existence and could be a target in treatment of infectious disease and cancer.

In summary, we highlight here new exciting developments regarding multi-faceted adenylate kinase biology, revealing the significance of mutations and modifications of this never resting phosphotransfer enzyme in energy support of cell motility, disease pathogenesis and regulation of cell differentiation and apoptosis.

8. Summary

Metabolic signals regulate and integrate many vital functions throughout the human body, including energy homeostasis, blood pressure, heart performance, food intake, hormonal status and brain performance. Growing evidence indicate the significance of metabolic monitors which directly sense cellular energy state and respond to imbalances by generating and delivering signaling molecules to metabolic sensors to produce a regulatory response. Adenylate kinase-mediated metabolic monitoring and downstream AMP signaling (AK → AMP → AMP-sensors) plays a critical role in the regulation of diverse cellular processes and serves as a primary stress-response pathway. Due to signaling to a number of AMP/nucleoside-sensitive cellular and extracellular components, adenylate kinase senses cellular energetic imbalances caused by physical activity, inadequate oxygenation or nutrient supply, generates and transmits feedback signals to adjust cellular energetics, substrate transport and vascular blood flow to facilitate oxygen and nutrient delivery. Adenylate kinase phosphotransfer dynamics regulates many diverse intracellular and extracellular nucleotide signaling processes, including excitation-contraction coupling, hormonal secretion, cell and ciliary motility, nuclear transport, energetics of cell cycle, DNA synthesis and break repair, and developmental programming. Moreover, adenylate kinase generated and modulated cellular, interstitial and blood AMP levels are emerging as potential metabolic signals that are associated with body energy sensing, sleep, hibernation, vascular flow and food intake. AMP is a mediator of antidiabetic drug action and has growing importance as a therapeutic agent. Within integrated phosphotransfer network, adenylate kinase is essential in integration and synchronization of metabolic sensors with the dynamics of cellular metabolism which is critical for regulation of genetic, energetic, electrical and signal transduction processes determining cell viability and functional activity. As such, adenylate kinase and AMP signaling components dispersed throughout the intracellular compartments, extracellular spaces and body fluids comprise a major metabolic monitoring and body energy sensing node transducing and distributing signals to metabolic sensors, thus conveying information about body energy and fuel usage status. Moreover, evidence is mounting regarding the direct relationship between defects in adenylate kinase and AMP metabolic signaling and human diseases, such as heart failure, hypertrophic cardiomyopathy, diabetes, obesity, hemolytic anemia, reticular dysgenesis, ciliary dyskinesia, cancer and neurodegeneration. Thus, adenylate kinase, previously considered as a regular housekeeping enzyme, is a critical player in metabolic monitoring and systemic integration of different signaling pathways to ensure cellular energy homeostasis and an adequate response to a broad range of functional, environmental and stress challenges.

Acknowledgments

This work was supported by grants from the National Institutes of Health, Marriott Heart Disease Research Program and Marriott Foundation. A.T. holds the Mayo Clinic Marriott Family Professorship in Cardiovascular Research. The authors thank to Dr. C. Folmes for critical reading of the manuscript and valuable suggestions.

References and Notes

1. Dzeja PP, Zelenznikar RJ, Goldberg ND. Adenylate kinase: kinetic behaviour in intact cells indicates it is integral to multiple cellular processes. Mol. Cell. Biochem. 1998;184:169–182. [PubMed]

2. Noma T. Dynamics of nucleotide metabolism as a supporter of life phenomena. J. Med. Invest. 2005;52:127–136. [PubMed]

3. Abrusci P, Chiarelli LR, Galizzi A, Fermo E, Bianchi P, Zanella A, Valentini G. Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia. Exp. Hematol. 2007;35:1182–1189. [PubMed]

4. Dzeja PP, Bast P, Pucar D, Wieringa B, Terzic A. Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow. J. Biol. Chem. 2007;282:31366–31372. [PMC free article] [PubMed]

5. Dzeja P, Chung S, Terzic A. Integration of adenylate kinase and glycolytic and clycogenolytic circuits in cellular energetics. In: Saks V, editor. Molecular System Bioenergetics Energy for Life. Wiley – VCH; Weinheim, Germany: 2007. pp. 265–301.

6. Lee HJ, Pyo JO, Oh Y, Kim HJ, Hong SH, Jeon YJ, Kim H, Cho DH, Woo HN, Song S, Nam JH, Kim HJ, Kim KS, Jung YK. AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat. Cell Biol. 2007;9:1303–1310. [PubMed]

7. Fernandez-Gonzalez A, Kourembanas S, Wyatt TA, Mitsialis SA. Mutation of murine adenylate kinase 7 underlies a primary ciliary dyskinesia phenotype. Am. J. Respir. Cell Mol. Biol. 2009;40:305–313. [PMC free article] [PubMed]

8. van Horssen R, Janssen E, Peters W, van de Pasch L, Lindert MM, van Dommelen MM, Linssen PC, Hagen TL, Fransen JA, Wieringa B. Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. J. Biol. Chem. 2009;284:1620–1627. [PubMed]

9. Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, Michel V, Ditadi A, Demerensde Chappedelaine C, Morillon E, Valensi F, Simon-Stoos KL, Mullikin JC, Noroski LM, Besse C, Wulffraat NM, Ferster A, Abecasis MM, Calvo F, Petit C, Candotti F, Abel L, Fischer A, Cavazzana-Calvo M. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat. Genet. 2009;41:106–111. [PMC free article] [PubMed]

10. Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, Barth TF, Rojewski MT, Schulz A, Boehm T, Friedrich W, Schwarz K. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat. Genet. 2009;41:101–105. [PubMed]

11. Rahlfs S, Koncarevic S, Iozef R, Mwongela Mailu B, Savvides SN, Schirmer RH, Becker K. Myristoylated adenylate kinase-2 of Plasmodium falciparum forms a heterodimer with myristoyltransferase. Mol. Biochem. Parasitol. 2009;163:77–84. [PubMed]

12. Savabi F, Geiger PJ, Bessman SP. Myokinase and contractile function of glycerinated muscle fibers. Biochem. Med. Metab. Biol. 1986;35:227–238. [PubMed]

13. Noda LH. Adenylate Kinase. In: Boyer PD, editor. The Enzymes. 3rd Ed. Volume 8. Academic Press; New York, USA: 1973. pp. 279–305.

14. Tanabe T, Yamada M, Noma T, Kajii T, Nakazawa A. Tissue-specific and developmentally regulated expression of the genes encoding adenylate kinase isozymes. J. Biochem. 1993;113:200–207. [PubMed]

15. Janssen E, Dzeja PP, Oerlemans F, Simonetti AW, Heerschap A, de Haan A, Rush PS, Terjung RR, Wieringa B, Terzic A. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J. 2000;19:6371–6381. [PubMed]

16. Criss WE. Relationship of ATP: AMP phosphotransferase isozymes to tissue respiration. Arch. Biochem. Biophys. 1971;144:138–142. [PubMed]

17. Walker EJ, Dow JW. Location and properties of two isoenzymes of cardiac adenylate kinase. Biochem. J. 1982;203:361–369. [PubMed]

18. Dzheia PP, Kalvenas AA, Toleikis AI, Prashkiavichius AK. Functional coupling of creatine phosphokinase and adenylate kinase with adenine nucleotide translocase and its role in regulation of heart mitochondrial respiration. Biokhimiia. 1983;48:1471–1478. [PubMed]

19. Schulz GE, Schiltz E, Tomasselli AG, Frank R, Brune M, Wittinghofer A, Schirmer RH. Structural relationships in the adenylate kinase family. Eur. J. Biochem. 1986;161:127–132. [PubMed]

20. Schoff PK, Cheetham J, Lardy HA. Adenylate kinase activity in ejaculated bovine sperm flagella. J. Biol. Chem. 1989;264:6086–6091. [PubMed]

21. Gellerich FN. The role of adenylate kinase in dynamic compartmentation of adenine nucleotides in the mitochondrial intermembrane space. FEBS Lett. 1992;297:55–58. [PubMed]

22. Qualtieri A, Pedace V, Bisconte MG, Bria M, Gulino B, Andreoli V, Brancati C. Severe erythrocyte adenylate kinase deficiency due to homozygous A → G substitution at codon 164 of human AK1 gene associated with chronic haemolytic anaemia. Br. J. Haematol. 1997;99:770–776. [PubMed]

23. Yoneda T, Sato M, Maeda M, Takagi H. Identification of a novel adenylate kinase system in the brain: cloning of the fourth adenylate kinase. Brain. Res. Mol. Brain. Res. 1998;62:187–195. [PubMed]

24. Yan H, Tsai MD. Nucleoside monophosphate kinases: structure, mechanism, and substrate specificity. Adv. Enzymol. Relat. Areas Mol. Biol. 1999;73:103–134. [PubMed]

25. Bae E, Phillips GN., Jr Roles of static and dynamic domains in stability and catalysis of adenylate kinase. Proc. Natl. Acad. Sci. U S A. 2006;103:2132–2137. [PubMed]

26. Dzeja P, Kalvenas A, Toleikis A, Praskevicius A. The effect of adenylate kinase activity on the rate and efficiency of energy transport from mitochondria to hexokinase. Biochem. Int. 1985;10:259–265. [PubMed]

27. Zeleznikar RJ, Heyman RA, Graeff RM, Walseth TF, Dawis SM, Butz EA, Goldberg ND. Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle. J. Biol. Chem. 1990;265:300–311. [PubMed]

28. Dzeja PP, Zeleznikar RJ, Goldberg ND. Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J. Biol. Chem. 1996;271:12847–12851. [PubMed]

29. Dzeja PP, Terzic A. Phosphotransfer networks and cellular energetics. J. Exp. Biol. 2003;206:2039–2047. [PubMed]

30. Dzeja PP, Terzic A. Mitochondrial-nucleus energetic communication: Role of phosphotransfer networks in processing cellular information. In: Gibson G, Dienel G, editors. Handbook of Neurochemistry & Molecular Neurobiology: Brain Energetics: Integration of Molecular and Cellular Processes. Volume 5. Springer; New York, USA: 2007. pp. 641–666.

31. Dzeja PP, Vitkevicius KT, Redfield MM, Burnett JC, Terzic A. Adenylate kinasecatalyzed phosphotransfer in the myocardium: increased contribution in heart failure. Circ. Res. 1999;84:1137–1143. [PubMed]

32. Pucar D, Janssen E, Dzeja PP, Juranic N, Macura S, Wieringa B, Terzic A. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. J. Biol. Chem. 2000;275:41424–41429. [PubMed]

33. Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B, Terzic A. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc. Natl. Acad. Sci. USA. 2001;98:7623–7628. [PubMed]

34. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL, Terzic A. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc. Natl. Acad. Sci. USA. 2002;99:10156–10161. [PubMed]

35. Pucar D, Bast P, Gumina RJ, Lim L, Drahl C, Juranic N, Macura S, Janssen E, Wieringa B, Terzic A, Dzeja PP. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. Am. J. Physiol. 2002;283:H776–H782. [PubMed]

36. Dzeja PP, Terzic A, Wieringa B. Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Mol. Cell. Biochem. 2004;256–257:13–27. [PubMed]

37. Selivanov VA, Alekseev AE, Hodgson DM, Dzeja PP, Terzic A. Nucleotide-gated KATP channels integrated with creatine and adenylate kinases: Amplification, tuning and sensing of energetics signals in the compartmentalized cellular environment. Mol. Cell. Biol. 2004;256–257:243–256. [PMC free article] [PubMed]

38. Dzeja PP, Pucar D, Bast P, Juranic N, Macura S, Terzic A. Captured cellular adenylate kinase-catalyzed phosphotransfer using ¹⁸O-assisted ³¹P NMR. MAGMA. 2002;14:180–181.

39. Janssen E, Terzic A, Wieringa B, Dzeja PP. Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice. J. Biol. Chem. 2003;278:30441–30449. [PubMed]

40. Hancock CR, Janssen E, Terjung RL. Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice. Am. J. Physiol. 2005;288:C1287–C1297. [PubMed]

41. Dzeja PP, Terzic A. Adenylate kinase and creatine kinase phosphotransfer in the regulation of mitochondrial respiration and cellular energetic efficiency. In: Vial C, Uversky VN, editors. Creatine Kinase Biochemistry, Physiology, Structure and Function. Nova Science; New York, USA: 2006. pp. 195–221.

42. Hancock CR, Janssen E, Terjung RL. Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice. J. Appl. Physiol. 2006;100:406–413. [PubMed]

43. Ingwall JS. Transgenesis and cardiac energetics: new insights into cardiac metabolism. J. Mol. Cell. Cardiol. 2004;37:613–623. [PubMed]

44. Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A, Wallimann T. Cardiac system bioenergetics: metabolic basis of Frank-Starling law. J. Physiol. 2006;571:253–273. [PubMed]

45. Olson LK, Schroeder W, Robertson RP, Goldberg ND, Walseth TF. Suppression of adenylate kinase catalyzed phosphotransfer precedes and is associated with glucose-induced insulin secretion in intact HIT-T15 cells. J. Biol. Chem. 1996;271:16544–16552. [PubMed]

46. Schulze DU, Düfer M, Wieringa B, Krippeit-Drews P, Drews G. An adenylate kinase is involved in K-ATP channel regulation of mouse pancreatic beta cells. Diabetologia. 2007;50:2126–2134. [PubMed]

47. Stanojevic V, Habener JF, Holz GG, Leech CA. Cytosolic adenylate kinases regulate KATP channel activity in human beta-cells. Biochem. Biophys. Res. Commun. 2008;368:614–619. [PMC free article] [PubMed]

48. Dzeja PP, Redfield MM, Burnett JC, Terzic A. Failing energetics in failing hearts. Curr. Cardiol. Rep. 2000;2:212–217. [PubMed]

49. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A, Redfield MM. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am. J. Physiol. 2003;284:H1313–H1320. [PubMed]

50. Cha YM, Dzeja PP, Redfield MM, Shen WK, Terzic A. Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat. Am. J. Physiol. 2006;290:H1686–H692. [PubMed]

51. Collavin L, Lazarevic D, Utrera R, Marzinotto S, Monte M, Schneider C. Wt p53 dependent expression of a membrane-associated isoform of adenylate kinase. Oncogene. 1999;18:5879–5888. [PubMed]

52. Neumann D, Schlattner U, Wallimann T. A molecular approach to the concerted action of kinases involved in energy homoeostasis. Biochem. Soc. Trans. 2003;31:169–174. [PubMed]

53. Swinnen JV, Beckers A, Brusselmans K, Organe S, Segers J, Timmermans L, Vanderhoydonc F, Deboel L, et al. Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype. Cancer Res. 2005;65:2441–2448. [PubMed]

54. Ren H, Wang L, Bennett M, Liang Y, Zheng X, Lu F, Li L, Nan J, Luo M, Eriksson S, Zhang C, Su XD. The crystal structure of human adenylate kinase 6: An adenylate kinase localized to the cell nucleus. Proc. Natl. Acad. Sci. USA. 2005;102:303–308. [PubMed]

55. Kun E, Kirsten E, Hakam A, Bauer PI, Mendeleyev J. Identification of poly(ADP-ribose) polymerase-1 as the OXPHOS-generated ATP sensor of nuclei of animal cells. Biochem. Biophys. Res. Commun. 2008;366:568–573. [PubMed]

56. Ginger ML, Ngazoa ES, Pereira CA, Pullen TJ, Kabiri M, Becker K, Gull K, Steverding D. Intracellular positioning of isoforms explains an unusually large adenylate kinase gene family in the parasite Trypanosoma brucei. J. Biol. Chem. 2005;280:11781–11789. [PubMed]

57. Cao W, Haig-Ladewig L, Gerton GL, Moss SB. Adenylate kinases 1 and 2 are part of the accessory structures in the mouse sperm flagellum. Biol. Reprod. 2006;75:492–500. [PubMed]

58. Ford WC. Glycolysis and sperm motility: does a spoonful of sugar help the flagellum go round? Hum. Reprod. Update. 2006;12:269–274. [PubMed]

59. Bouvier LA, Miranda MR, Canepa GE, Alves MJ, Pereira CA. An expanded adenylate kinase gene family in the protozoan parasite Trypanosoma cruzi. Biochim. Biophys. Acta. 2006;1760:913–921. [PubMed]

60. Pucar D, Dzeja PP, Bast P, Gumina RJ, Drahl C, Lim L, Juranic N, Macura S, Terzic A. Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by ¹⁸Oassisted ³¹P NMR and ¹H NMR spectroscopy. Mol. Cell. Biochem. 2004;256–257:281–289. [PMC free article] [PubMed]

61. Dzeja PP, Terzic A. Phosphotransfer reactions in the regulation of ATP-sensitive K⁺ channels. FASEB J. 1998;12:523–529. [PubMed]

62. Hardie DG. The AMP-activated protein kinase pathway–new players upstream and downstream. J. Cell Sci. 2004;117:5479–5487. [PubMed]

63. Frederich M, Balschi JA. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J. Biol. Chem. 2002;277:1928–1932. [PubMed]

64. Yegutkin GG, Henttinen T, Jalkanen S. Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J. 2001;15:251–260. [PubMed]

65. Picher M, Boucher RC. Human airway ecto-adenylate kinase. A mechanism to propagate ATP signaling on airway surfaces. J. Biol. Chem. 2003;278:11256–11264. [PubMed]

66. Zhang J, Kaasik K, Blackburn MR, Lee CC. Constant darkness is a circadian metabolic signal in mammals. Nature. 2006;439:340–343. [PubMed]

67. Lee CC. Constant darkness is a mammalian biological signal. Cold Spring Harb. Symp. Quant. Biol. 2007;72:287–291. [PubMed]

68. Cha SH, Wolfgang M, Tokutake Y, Chohnan S, Lane MD. Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proc. Natl. Acad. Sci. USA. 2008;105:16871–16875. [PubMed]

69. Scharf MT, Naidoo N, Zimmerman JE, Pack AI. The energy hypothesis of sleep revisited. Prog. Neurobiol. 2008;86:264–280. [PMC free article] [PubMed]

70. Wirschell M, Pazour G, Yoda A, Hirono M, Kamiya R, Witman GB. Oda5p, a novel axonemal protein required for assembly of the outer Dynein arm and an associated adenylate kinase. Mol. Biol. Cell. 2004;15:2729–2741. [PMC free article] [PubMed]

71. Weiss JN, Yang L, Qu Z. Systems biology approaches to metabolic and cardiovascular disorders: network perspectives of cardiovascular metabolism. J. Lipid. Res. 2006;47:2355–2366. [PubMed]

72. Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (London) 2008;32:S7–S12. [PubMed]

73. Janssen E, Kuiper J, Hodgson D, Zingman LV, Alekseev AE, Terzic A, Wieringa B. Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain. Mol. Cell. Biochem. 2004;256–257:59–72. [PubMed]

74. Walker EJ, Dow JW. Location and properties of two isoenzymes of cardiac adenylate kinase. Biochem. J. 1982;203:361–369. [PubMed]

75. Tomasselli AG, Schirmer RH, Noda LH. Mitochondrial GTP-AMP phosphotransferase. 1. Purification and properties. Eur. J. Biochem. 1979;93:257–262. [PubMed]

76. Lange S, Auerbach D, McLoughlin P, Perriard E, Schafer BW, Perriard JC, Ehler E. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 2002;115:4925–4936. [PubMed]

77. Wild K, Grafmuller R, Wagner E, Schulz GE. Structure, catalysis and supramolecular assembly of adenylate kinase from maize. Eur. J. Biochem. 1997;250:326–331. [PubMed]

78. Klier H, Magdolen V, Schricker R, Strobel G, Lottspeich F, Bandlow W. Cytoplasmic and mitochondrial forms of yeast adenylate kinase 2 are N-acetylated. Biochim. Biophys. Acta. 1996;1280:251–256. [PubMed]

79. Fratelli M, Demol H, Puype M, Casagrande S, Villa P, Eberini I, Vandekerckhove J, Gianazza E, Ghezzi P. Identification of proteins undergoing glutathionylation in oxidatively stressed hepatocytes and hepatoma cells. Proteomics. 2003;3:1154–1161. [PubMed]

80. Luz CM, Konig I, Schirmer RH, Frank R. Human cytosolic adenylate kinase allelozymes; purification and characterization. Biochim. Biophys. Acta. 1990;1038:80–84. [PubMed]

81. Lee Y, Kim JW, Lee SM, Kim HJ, Lee KS, Park C, Choe IS. Cloning and expression of human adenylate kinase 2 isozymes: differential expression of adenylate kinase 1 and 2 in human muscle tissues. J. Biochem. 1998;123:47–54. [PubMed]

82. Gloria-Bottini F, Magrini A, Pietropolli A, Bergamaschi A, Bottini E. Smoking and human reproduction: the effect of adenylate kinase genetic polymorphism. Am. J. Perinatol. 2009;26:117–121. [PubMed]

83. Liu R, Ström AL, Zhai J, Gal J, Bao S, Gong W, Zhu H. Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase. Int. J. Biochem. Cell Biol. 2009;41:1371–1380. [PMC free article] [PubMed]

84. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000;14:1983–1991. [PubMed]

85. Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, Simon MC. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol. 2006;26:3514–3526. [PMC free article] [PubMed]

86. Tüzün E, Rossi JE, Karner SF, Centurion AF, Dalmau J. Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J. Neuroimmunol. 2007;186:177–180. [PMC free article] [PubMed]

87. Ruan Q, Chen Y, Gratton E, Glaser M, Mantulin WW. Cellular characterization of adenylate kinase and its isoform: two-photon excitation fluorescence imaging and fluorescence correlation spectroscopy. Biophys. J. 2002;83:3177–3187. [PubMed]

88. Vasseur S, Malicet C, Calvo EL, Dagorn JC, Iovanna JL. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development. Mol. Cancer. 2005;4:4–11. [PMC free article] [PubMed]

89. Bonilha VL, Bhattacharya SK, West KA, Sun J, Crabb JW, Rayborn ME, Hollyfield JG. Proteomic characterization of isolated retinal pigment epithelium microvilli. Mol. Cell Prot. 2004;3:1119–1127. [PubMed]

90. Santama N, Ogg SC, Malekkou A, Zographos SE, Weis K, Lamond AI. Characterization of hCINAP, a novel coilin-interacting protein encoded by a transcript from the transcription factor TAFIID32 locus. J. Biol. Chem. 2005;280:36429–36441. [PubMed]

91. Zhai R, Meng G, Zhao Y, Liu B, Zhang G, Zheng X. A novel nuclear-localized protein with special adenylate kinase properties from Caenorhabditis elegans. FEBS Lett. 2006;580:3811–3817. [PubMed]

92. Juhnke H, Charizanis C, Latifi F, Krems B, Entian KD. The essential protein fap7 is involved in the oxidative stress response of Saccharomyces cerevisiae. Mol. Microbiol. 2000;35:936–948. [PubMed]

93. Bhaskara V, Dupré A, Lengsfeld B, Hopkins BB, Chan A, Lee JH, Zhang X, Gautier J, Zakian V, Paull TT. Rad50 adenylate kinase activity regulates DNA tethering by Mre11/Rad50 complexes. Mol. Cell. 2007;25:647–661. [PMC free article] [PubMed]

94. Lee JH, Ghirlando R, Bhaskara V, Hoffmeyer MR, Gu J, Paull TT. Regulation of Mre11/Rad50 by Nbs1: effects on nucleotide-dependent DNA binding and association with ataxia-telangiectasia-like disorder mutant complexes. J. Biol. Chem. 2003;278:45171–45181. [PubMed]

95. Paull TT, Gellert M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 1999;13:1276–1288. [PubMed]

96. Lonergan KM, Chari R, Deleeuw RJ, Shadeo A, Chi B, Tsao MS, Jones S, Marra M, Ling V, Ng R, Macaulay C, Lam S, Lam WL. Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression. Am. J. Respir. Cell. Mol. Biol. 2006;35:651–661. [PubMed]

97. Scheible D, Kowtharapu BS, Hamprecht B, Verleysdonk S. Adenylate kinase 7 is a differentiation marker of kinocilia-bearing cells. BMC Neurosci. 2007;8:7. [PubMed]

98. Stubbs JL, Oishi I, Izpisúa Belmonte JC, Kintner C. The forkhead protein Foxj1 specifies node-like cilia in Xenopus and zebrafish embryos. Nat. Genet. 2008;40:1454–1460. [PubMed]

99. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS. Identification of genes that regulate epithelial cell migration using a siRNA screening approach. Nat. Cell Biol. 2008;10:1027–1038. [PubMed]

100. Kinukawa M, Nomura M, Vacquier VD. A sea urchin sperm flagellar adenylate kinase with triplicated catalytic domains. J. Biol. Chem. 2007;282:2947–2955. [PubMed]

101. Bandlow W, Strobel G, Zoglowek C, Oechsner U, Magdolen V. Yeast adenylate kinase is active simultaneously in mitochondria and cytoplasm and is required for non-fermentative growth. Eur. J. Biochem. 1988;178:451–457. [PubMed]

102. Savabi F. Interaction of creatine kinase and adenylate kinase systems in muscle cells. Mol. Cell. Biochem. 1994;133–134:145–152. [PubMed]

103. Clark JF, Kuznetsov AV, Radda GK. ADP-regenerating enzyme systems in mitochondria of guinea pig myometrium and heart. Am. J. Physiol. 1997;272:C399–C404. [PubMed]

104. Nakatsu K, Drummond GI. Adenylate metabolism and adenosine formation in the heart. Am. J. Physiol. 1972;223:1119–1127. [PubMed]

105. Seccia TM, Atlante A, Vulpis V, Marra E, Passarella S, Pirrelli A. Mitochondrial energy metabolism in the left ventricular tissue of spontaneously hypertensive rats: abnormalities in both adeninenucleotide and phosphate translocators and enzyme adenylate kinase and creatine phosphokinase activities. Clin. Exp. Hypertens. 1998;20:345–358. [PubMed]

106. Seifert O, Bayat A, Geffers R, Dienus K, Buer J, Löfgren S, Matussek A. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen. 2008;16:254–265. [PubMed]

107. O’Rourke JF, Pugh CW, Bartlett SM, Ratcliffe PJ. Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur. J. Biochem. 1996;241:403–410. [PubMed]

108. Linossier MT, Dormois D, Perier C, Frey J, Geyssant A, Denis C. Enzyme adaptations of human skeletal muscle during bicycle short-sprint training and detraining. Acta Physiol. Scand. 1997;161:439–445. [PubMed]

109. Ge Y, Molloy MP, Chamberlain JS, Andrews PC. Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics. 2003;3:1895–1903. [PubMed]

110. Hittel DS, Hathout Y, Hoffman EP, Houmard JA. Proteome analysis of skeletal muscle from obese and morbidly obese women. Diabetes. 2005;54:1283–1288. [PubMed]

111. Wegmann G, Zanolla E, Eppenberger HM, Wallimann T. In situ compartmentation of creatine kinase in intact sarcomeric muscle: the acto-myosin overlap zone as a molecular sieve. J. Muscle Res. Cell Motil. 1992;13:420–435. [PubMed]

112. Inouye S, Yamada Y, Miura K, Suzuki H, Kawata K, Shinoda K, Nakazawa A. Distribution and developmental changes of adenylate kinase isozymes in the rat brain: localization of adenylate kinase 1 in the olfactory bulb. Biochem. Biophys. Res. Commun. 1999;254:618–622. [PubMed]

113. Gerlach G, Hofer HW. Interaction of immobilized phosphofructokinase with soluble muscle proteins. Biochim. Biophys. Acta. 1986;881:398–404. [PubMed]

114. Girouard J, Frenette G, Sullivan R. Seminal plasma proteins regulate the association of lipids and proteins within detergent-resistant membrane domains of bovine spermatozoa. Biol. Reprod. 2008;78:921–931. [PubMed]

115. Kim J, Shen R, Olcott MC, Rajagopal I, Mathews CK. Adenylate kinase of Escherichia coli, a component of the phage T4 dNTP synthetase complex. J. Biol. Chem. 2005;280:28221–28229. [PubMed]

116. Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B, Dzeja P, Alekseev AE, Terzic A. Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J. Biol. Chem. 2002;277:24427–24434. [PubMed]

117. Welch GR. On the role of organized multienzyme systems in cellular metabolism: a general synthesis. Prog. Biophys. Mol. Biol. 1977;32:103–191. [PubMed]

118. Mair T, Muller SC. Traveling NADH and proton waves during oscillatory glycolysis in vitro. J. Biol. Chem. 1996;271:627–630. [PubMed]

119. Kohen E, Welch GR, Kohen C, Hirschberg JG, Bereiter-Hahn J. Experimental Analysis of Spatiotemporal Organization of Metabolism in Intact Cells: The Enigma of “Metabolic Channeling” and “Metabolic Compartmentation” In: Welch GR, Clegg JS, editors. The Organization of Cell Metabolism. Volume 127. Springer; New York, USA: 1987. pp. 251–275.

120. Pucar D, Dzeja PP, Bast P, Juranic N, Macura S, Terzic A. Cellular energetics in the preconditioned state: protective role for phosphotransfer reactions captured by ¹⁸O-assisted ³¹P NMR. J. Biol. Chem. 2001;276:44812–44819. [PubMed]

121. Bunger R, Soboll S. Cytosolic adenylates and adenosine release in perfused working heart. Comparison of whole tissue with cytosolic non-aqueous fractionation analyses. Eur. J. Biochem. 1986;159:203–213. [PubMed]

122. Leclerc I, Woltersdorf WW, da Silva Xavier G, Rowe RL, Cross SE, Korbutt GS, Rajotte RV, Smith R, Rutter GA. Metformin, but not leptin, regulates AMP-activated protein kinase in pan-creatic islets: impact on glucose-stimulated insulin secretion. Am. J. Physiol. 2004;286:E1023–E1031. [PubMed]

123. de Groof AJ, Oerlemans FT, Jost CR, Wieringa B. Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles. Muscle Nerve. 2001;24:1188–1196. [PubMed]

124. Janssen E, de Groof A, Wijers M, Fransen J, Dzeja PP, Terzic A, Wieringa B. Adenylate kinase 1 deficiency induces molecular and structural adaptations to support muscle energy metabolism. J. Biol. Chem. 2003;278:12937–12945. [PubMed]

125. Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O’Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang YP, Alekseev AE, Terzic A. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic K-ATP channel gating. Nat. Genet. 2004;36:382–387. [PMC free article] [PubMed]

126. Zeleznikar RJ, Dzeja PP, Goldberg ND. Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle. J. Biol. Chem. 1995;270:7311–7319. [PubMed]

127. Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol. 2006;574:95–112. [PubMed]

128. Young LH, Li J, Baron SJ, Russell RR. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc. Med. 2005;15:110–118. [PubMed]

129. Hasegawa T, Bouïs D, Liao H, Visovatti SH, Pinsky DJ. Ecto-5′ nucleotidase (CD73)- mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ. Res. 2008;103:1410–1421. [PubMed]

130. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Directed inhibition of nuclear import in cellular hypertrophy. J. Biol. Chem. 2001;276:20566–20571. [PubMed]

131. Brewster LM, Mairuhu G, Bindraban NR, Koopmans RP, Clark JF, van Montfrans GA. Creatine kinase activity is associated with blood pressure. Circulation. 2006;114:2034–2039. [PubMed]

132. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, Salt IP. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J. Biol. Chem. 2003;278:31629–31639. [PubMed]

133. Rubin LJ, Magliola L, Feng X, Jones AW, Hale CC. Metabolic activation of AMP kinase in vascular smooth muscle. J. Appl. Physiol. 2005;98:296–306. [PubMed]

134. Wyatt CN, Mustard KJ, Pearson SA, Dallas ML, Atkinson L, Kumar P, Peers C, Hardie DG, Evans AM. AMP-activated protein kinase mediates carotid body excitation by hypoxia. J. Biol. Chem. 2007;282:8092–8098. [PMC free article] [PubMed]

135. Andrade FH, Merriam AP, Guo W, Cheng G, McMullen CA, Hayess K, van der Ven PF, Porter JD. Paradoxical absence of M lines and downregulation of creatine kinase in mouse extraocular muscle. J. Appl. Physiol. 2003;95:692–699. [PubMed]

136. Kuehnel MP, Reiss M, Anand PK, Treede I, Holzer D, Hoffmann E, Klapperstueck M, Steinberg TH, Markwardt F, Griffiths G. Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation. J. Cell Sci. 2009;122:505–512. [PubMed]

137. Blaustein DN, Simmons RB, Burgess MF, Derby CD, Nishikawa M, Olson KS. Ultrastructural localization of 5′AMP odorant receptor sites on the dendrites of olfactory receptor neurons of the spiny lobster. J. Neurosci. 1993;13:2821–2828. [PubMed]

138. Templeton GW, Moorhead GB. A renaissance of metabolite sensing and signaling: from modular domains to riboswitches. Plant Cell. 2004;16:2252–2257. [PubMed]

139. Wakeman CA, Winkler WC, Dann CE., III Structural features of metabolite-sensing riboswitches. Trends Biochem Sci. 2007;32:415–424. [PMC free article] [PubMed]

140. Fabre AC, Vantourout P, Champagne E, Terce F, Rolland C, Perret B, Collet X, Barbaras R, Martinez LO. Cell surface adenylate kinase activity regulates the F(1)- ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol. Life Sci. 2006;63:2829–2837. [PMC free article] [PubMed]

141. Quillen EE, Haslam GC, Samra HS, Amani-Taleshi D, Knight JA, Wyatt DE, Bishop SC, Colvert KK, Richter ML, Kitos PA. Ectoadenylate kinase and plasma membrane ATP synthase activities of human vascular endothelial cells. J. Biol. Chem. 2006;281:20728–20737. [PubMed]

142. Winkler WC. Metabolic monitoring by bacterial mRNAs. Arch. Microbiol. 2005;183:151–159. [PubMed]

143. Reznick RM, Shulman GI. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 2006;574:33–39. [PubMed]

144. Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J. Clin. Invest. 2007;117:1432–1439. [PMC free article] [PubMed]

145. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Invest. 2002;109:357–362. [PMC free article] [PubMed]

146. Schlattner U, Wagner E, Greppin H, Bonzon M. Multiple adenylate kinase isoforms in higher plants. Arch. Sci. 1996;49:21–33.

147. Regierer B, Fernie AR, Springer F, Perez-Melis A, Leisse A, Koehl K, Willmitzer L, Geigenberger P, Kossmann J. Starch content and yield increase as a result of altering adenylate pools in transgenic plants. Nat. Biotechnol. 2002;20:1256–1260. [PubMed]

148. Carrari F, Coll-Garcia D, Schauer N, Lytovchenko A, Palacios-Rojas N, Balbo I, Rosso M, Fernie AR. Deficiency of a plastidial adenylate kinase in Arabidopsis results in elevated photosynthetic amino acid biosynthesis and enhanced growth. Plant Physiol. 2005;137:70–82. [PubMed]

149. Sakai Y, Rogi T, Yonehara T, Kato N, Tani Y. High-level ATP production by a genetically-engineered Candida yeast. Biotechnology (N Y) 1994;12:291–293. [PubMed]

150. Harold FM. Biochemical topology: from vectorial metabolism to morphogenesis. Biosci. Rep. 1991;11:347–385. [PubMed]

151. Zhang L, He H, Balschi JA. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am. J. Physiol. 2007;293:H457–H466. [PubMed]

152. Corvera S, Burkart A, Kim JY, Christianson J, Wang Z, Scherer PE. Keystone meeting summary: ‘Adipogenesis, obesity, and inflammation’ and ‘Diabetes mellitus and the control of cellular energy metabolism’. January 21–26, 2006, Vancouver, Canada. Genes Dev. 2006;20:2193–2201. [PubMed]

153. Moore F, Weekes J, Hardie DG. Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. Eur. J. Biochem. 1991;199:691–697. [PubMed]

154. Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, Keim NL, Cummings BP, Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses J. Clin. Endocrinol. Metab 2009. In press. [PubMed]

155. Mäenpää PH, Raivio KO, Kekomäki MP. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science. 1968;161:1253–1254. [PubMed]

156. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007;86:899–906. [PubMed]

157. Vasdev S, Longerich L, Gill V. Prevention of fructose-induced hypertension by dietary vitamins. Clin. Biochem. 2004;37:1–9. [PubMed]

158. Raatikainen MJ, Peuhkurinen KJ, Kiviluoma KT, Hiltunen JK, Hassinen IE. 5′-Nucleotidase activity and adenosine production in rat liver mitochondria. Biochim. Biophys. Acta. 1992;1099:238–246. [PubMed]

159. Kono H, Bode JC, Martini GA. Effect of acute and chronic ethanol administration on the content of coenzymes linked to energy transfer in the liver of rats fed standard or low-protein diet. Gastroenterol. Jpn. 1979;14:226–232. [PubMed]

160. Williams SP, Newton RP, Brown EG. Analysis of the effects of ethanol, fructose and nicotinamide on the free nucleotides of rat liver using high performance liquid chromatography. Int. J. Biochem. 1987;19:879–884. [PubMed]

161. Williams KW, Coppari R, Elmquist JK. “AMPing up” our understanding of the hypothalamic control of energy balance. J. Clin. Invest. 2007;117:2089–2092. [PMC free article] [PubMed]

162. Krenz M, Baines CP, Heusch G, Downey JM, Cohen MV. Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J. Mol. Cell Cardiol. 2001;33:2015–2022. [PubMed]

163. Jordan JE, Simandle SA, Tulbert CD, Busija DW, Miller AW. Fructose-fed rats are protected against ischemia/reperfusion injury. J. Pharmacol. Exp. Ther. 2003;307:1007–1011. [PubMed]

164. Gorman MW, Marble DR, Ogimoto K, Feigl EO. Measurement of adenine nucleotides in plasma. Luminescence. 2003;18:173–181. [PubMed]

165. Harrison GJ, Willis RJ, Headrick JP. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc. Res. 1998;40:74–87. [PubMed]

166. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, Shaham O, Berriz G, Lowry PA, Palacios IF, Taşan M, Roth FP, Min J, Baumgartner C, Keshishian H, Addona T, Mootha VK, Rosenzweig A, Carr SA, Fifer MA, Sabatine MS, Gerszten RE. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J. Clin. Invest. 2008;118:3503–3512. [PMC free article] [PubMed]

167. Atanassov CL, Naegeli HU, Zenke G, Schneider C, Kramarova LI, Bronnikov GE, Van Regenmortel MH. Anti-lymphoproliferative activity of brown adipose tissue of hibernating ground squirrels is mainly caused by AMP. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 1995;112:93–100. [PubMed]

168. Brambilla D, Chapman D, Greene R. Adenosine mediation of presynaptic feedback inhibition of glutamate release. Neuron. 2005;46:275–283. [PubMed]

169. Bjorness TE, Kelly CL, Gao T, Poffenberger V, Greene RW. Control and function of the homeostatic sleep response by adenosine A1 receptors. J. Neurosci. 2009;291:267–1276. [PMC free article] [PubMed]

170. Salton S. Neurotrophins, growth-factor-regulated genes and the control of energy balance. Mt. Sinai J. Med. 2003;70:93–100. [PubMed]

171. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002;8:1288–1295. [PubMed]

172. Li X, Han Y, Pang W, Li C, Xie X, Shyy JY, Zhu Y. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2008;28:1789–1795. [PMC free article] [PubMed]

173. Steinberg GR, Rush JW, Dyck DJ. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am. J. Physiol. 2003;284:E648–E654. [PubMed]

174. Steinberg GR, McAinch AJ, Chen MB, O’Brien PE, Dixon JB, Cameron-Smith D, Kemp BE. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J. Clin. Endocrinol. Metab. 2006;91:3592–3597. [PubMed]

175. Rossmeisl M, Flachs P, Brauner P, Sponarova J, Matejkova O, Prazak T, Ruzickova J, Bardova K, Kuda O, Kopecky J. Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores. Int. J. Obes. Relat. Metab. Disord. 2004;28:S38–S44. [PubMed]

176. Schrauwen P, Hesselink M. UCP2 and UCP3 in muscle controlling body metabolism. J. Exp. Biol. 2002;205:2275–2285. [PubMed]

177. Schrauwen P, Hardie DG, Roorda B, Clapham JC, Abuin A, Thomason-Hughes M, Green K, Frederik PM, Hesselink MK. Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase? Int. J. Obes. Relat. Metab. Disord. 2004;28:824–828. [PubMed]

178. Cadenas S, Buckingham JA, St-Pierre J, Dickinson K, Jones RB, Brand MD. AMP decreases the efficiency of skeletal-muscle mitochondria. Biochem. J. 2000;351:307–311. [PubMed]

179. Doran P, O’Connell K, Gannon J, Kavanagh M, Ohlendieck K. Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis. Proteomics. 2008;8:364–77. [PubMed]

180. Apfeld J, O’Connor G, McDonagh T, DiStefano PS, Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 2004;18:3004–3009. [PubMed]

181. Wang W, Yang X, López de Silanes I, Carling D, Gorospe M. Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J. Biol. Chem. 2003;278:27016–27023. [PubMed]

182. Zwerschke W, Mazurek S, Stöckl P, Hütter E, Eigenbrodt E, Jansen-Dürr P. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem. J. 2003;376:403–411. [PubMed]

183. Downs SM, Hudson ER, Hardie DG. A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes. Dev. Biol. 2002;245:200–212. [PubMed]

184. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee SH, Shong M, Kim JM, Kim J, Chung J. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature. 2007;447:1017–1020. [PubMed]

185. Brenman JE. AMPK/LKB1 signaling in epithelial cell polarity and cell division. Cell Cycle. 2007;6:2755–2759. [PubMed]

186. Hallows KR, Kobinger GP, Wilson JM, Witters LA, Foskett JK. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am. J. Physiol. 2003;284:C1297–C308. [PubMed]

187. Kongsuphol P, Cassidy D, Hieke B, Treharne KJ, Schreiber R, Mehta A, Kunzelmann K. Mechanistic insight into control of CFTR by AMPK. J. Biol. Chem. 2009;284:5645–5653. [PMC free article] [PubMed]

188. Randak CO, Welsh MJ. Role of CFTR’s intrinsic adenylate kinase activity in gating of the Cl(-) channel. J. Bioenerg. Biomembr. 2007;39:473–479. [PubMed]

189. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem. 2003;278:39422–39427. [PubMed]

190. Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 2005;280:32081–32089. [PubMed]

191. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 2000;348:607–614. [PubMed]

192. Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acids attenuate insulin regulation of 5′-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ. Res. 2006;99:61–68. [PubMed]

193. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. SA. 2007;104:7217–7222. [PubMed]

194. LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am. J. Physiol. 2006;291:E175–E181. [PubMed]

195. Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY. Statins activate AMPactivated protein kinase in vitro and in vivo. Circulation. 2006;114:2655–26562. [PubMed]

196. Boyle JG, Logan PJ, Ewart MA, Reihill JA, Ritchie SA, Connell JM, Cleland SJ, Salt IP. Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. J. Biol. Chem. 2008;283:11210–1127. [PubMed]

197. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342. [PubMed]

198. Kaneider NC, Egger P, Dunzendorfer S, Noris P, Balduini CL, Gritti D, Ricevuti G, Wiedermann CJ. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism. Arterioscler. Thromb. Vasc. Biol. 2002;22:894–900. [PubMed]

199. Yin J, Zhang H, Ye J. Traditional Chinese medicine in treatment of metabolic syndrome. Endocr. Metab. Immune Disord. Drug. Targets. 2008;8:99–111. [PMC free article] [PubMed]

200. Legtenberg RJ, Houston RJ, Oeseburg B, Smits P. Metformin improves cardiac functional recovery after ischemia in rats. Horm. Metab. Res. 2002;34:182–185. [PubMed]

201. Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M, Tian R, Lefer DJ. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ. Res. 2009;104:403–411. [PMC free article] [PubMed]

202. Saeedi R, Parsons HL, Wambolt RB, Paulson K, Sharma V, Dyck JR, Brownsey RW, Allard MF. Metabolic actions of metformin in the heart can occur by AMPKindependent mechanisms. Am. J. Physiol. 2008;294:H2497–H2506. [PubMed]

203. Flameng W. New strategies for intraoperative myocardial protection. Curr. Opin. Cardiol. 1995;10:577–583. [PubMed]

204. Peart JN, Headrick JP. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol. Ther. 2007;114:208–221. [PubMed]

205. Fischell TA, Haller S, Pulukurthy S, Virk IS. Nicardipine and adenosine “flush cocktail” to prevent no-reflow during rotational atherectomy. Cardiovasc. Revasc. Med. 2008;9:224–228. [PubMed]

206. Aymerich I, Foufelle F, Ferré P, Casado FJ, Pastor-Anglada M. Extracellular adenosine activates AMP-dependent protein kinase (AMPK) J. Cell Sci. 2006;119:1612–1621. [PubMed]

207. Ming D, Ninomiya Y, Margolskee RF. Blocking taste receptor activation of gustducin inhibits gustatory responses to bitter compounds. Proc. Natl. Acad. Sci. USA. 1999;96:9903–9908. [PubMed]

208. Carver JD. Dietary nucleotides: effects on the immune and gastrointestinal systems. Acta Paediatr. Suppl. 1999;88:83–88. [PubMed]

209. Wasserman HA, Singh S, Champagne DE. Saliva of the Yellow Fever mosquito, Aedes aegypti, modulates murine lymphocyte function. Paras. Immunol. 2004;26:295–306. [PubMed]

210. Munier-Lehmann H, Chenal-Francisque V, Ionescu M, Chrisova P, Foulon J, Carniel E, Bârzu O. Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent. Biochem. J. 2003;373:515–522. [PubMed]

211. Nath N, Giri S, Prasad R, Salem ML, Singh AK, Singh I. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J. Immunol. 2005;175:566–574. [PubMed]

212. Seeley RJ, York DA. Fuel sensing and the central nervous system (CNS): implications for the regulation of energy balance and the treatment for obesity. Obes. Rev. 2005;6:259–265. [PubMed]

213. Xue B, Kahn BB. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol. 2006;574:73–83. [PubMed]

214. Levin BE. Metabolic sensing neurons and the control of energy homeostasis. Physiol. Behav. 2006;89:486–489. [PubMed]

215. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda) 2007;22:241–251. [PubMed]

216. Woods SC, Seeley RJ, Cota D. Regulation of food intake through hypothalamic signaling networks involving mTOR. Annu. Rev. Nutr. 2008;28:295–311. [PubMed]

217. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr. Prob. Cardiol. 1994;19:57–116. [PubMed]

218. Saks V, Monge C, Guzun R, Dzeja P, Wallimann T. Wiley Encyclopedia of Chemical Biology. Volume 2. John Wiley & Sons; Hoboken, USA: 2009. Integrated and Organized Cellular Energetic Systems; pp. 366–393.

219. Carling D, Sanders MJ, Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int. J. Obes. (London) 2008;32:S55–S59. [PubMed]

220. McBride A, Ghilagaber S, Nikolaev A, Hardie DG. The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab. 2009;9:23–34. [PMC free article] [PubMed]

221. Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am. J. Physiol. 2008;295:R1370–R1375. [PubMed]

222. Kanig K, Hoffmann KH. 32P-incorporation in adenosine phosphates of the rat brain after oral application of vincamine for 2 weeks. Arzneimittelforschung. 1979;29:33–34. [PubMed]

223. Dawis SM, Graeff RM, Heyman RA, Walseth TF, Goldberg ND. Regulation of cyclic GMP metabolism in toad photoreceptors. Definition of the metabolic events subserving photoexcited and attenuated states. J. Biol. Chem. 1988;263:8771–8785. [PubMed]

224. Inouye S, Seo M, Yamada Y, Nakazawa A. Increase of adenylate kinase isozyme 1 protein during neuronal differentiation in mouse embryonal carcinoma P19 cells and in rat brain primary cultured cells. J. Neurochem. 1998;71:125–133. [PubMed]

225. Wu CS, Greenwood DR, Cooney JM, Jensen DJ, Tatnell MA, Cooper GJ, Mountjoy KG. Peripherally administered desacetyl alpha-MSH and alpha-MSH both influence postnatal rat growth and associated rat hypothalamic protein expression. Am. J. Physiol. 2006;291:E1372–E1380. [PubMed]

226. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004;428:569–574. [PubMed]

227. Aksu S, Koczan D, Renne U, Thiesen HJ, Brockmann GA. Differentially expressed genes in adipose tissues of high body weight-selected (obese) and unselected (lean) mouse lines. J. Appl. Genet. 2007;48:133–143. [PubMed]

228. Hsu YM, Lai CH, Chang CY, Fan CT, Chen CT, Wu CH. Characterizing the lipidlowering effects and antioxidant mechanisms of tomato paste. Biosci. Biotechnol. Biochem. 2008;72:677–685. [PubMed]

229. Laughlin SB. Energy as a constraint on the coding and processing of sensory information. Curr. Opin. Neurobiol. 2001;11:475–480. [PubMed]

230. Gjedde A. Brain Energy Metabolism and the Physiological Basis of the Haemodynamic Response. In: Jezzard P, Matthews PM, Smith S, editors. Functional MRI - an Introduction to Methods. Oxford University Press; Oxford, UK: 2001. pp. 37–65.

231. Nagy AK, Shuster TA, Delgado-Escueta AV. Rat brain synaptosomal ATP:AMPphosphotransferase activity. J. Neurochem. 1989;53:1166–1172. [PubMed]

232. van den Berge M, Polosa R, Kerstjens HA, Postma DS. The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2004;114:737–746. [PubMed]

233. Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 2001;79:463–484. [PubMed]

234. Adelman RC, Lo CH, Weinhouse S. Adenylate kinase activity in rat liver. Adv. Enz. Reg. 1968;6:425–436. [PubMed]

235. Carvajal K, El-Hafidi M, Marin-Hernandez A, Moreno-Sanchez R. Structural and functional changes in heart mitochondria from sucrose-fed hypertriglyceridemic rats. Biochim. Biophys. Acta. 2005;1709:231–239. [PubMed]

236. Bianchi P, Zappa M, Bredi E, Vercellati C, Pelissero G, Barraco F, Zanella A. A case of complete adenylate kinase deficiency due to a nonsense mutation in AK-1 gene (Arg 107 → Stop, CGA → TGA) associated with chronic haemolytic anaemia. Br. J. Haematol. 1999;105:75–79. [PubMed]

237. de Lange P, Ragni M, Silvestri E, Moreno M, Schiavo L, Lombardi A, Farina P, Feola A, Goglia F, Lanni A. Combined cDNA array/RT-PCR analysis of gene expression profile in rat gastrocnemius muscle: relation to its adaptive function in energy metabolism during fasting. FASEB J. 2004;18:350–352. [PubMed]

238. Jackson EK, Mi Z, Zhu C, Dubey RK. Adenosine biosynthesis in the collecting duct. J. Pharmacol. Exp. Ther. 2003;307:888–896. [PubMed]

239. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem. 1999;72:1707–1716. [PubMed]

240. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ. Res. 1980;47:807–813. [PubMed]

241. Minami K, Miki T, Kadowaki T, Seino S. Roles of ATP-sensitive K⁺ channels as metabolic sensors: studies of Kir6.x null mice. Diabetes. 2004;53:S176–S180. [PubMed]

242. Tarasov A, Dusonchet J, Ashcroft F. Metabolic regulation of the pancreatic beta-cell ATPsensitive K⁺ channel: a pas de deux. Diabetes. 2004;53:S113–S122. [PubMed]

243. Carling D. The AMP-activated protein kinase cascade–a unifying system for energy control. Trends Biochem. Sci. 2004;29:18–24. [PubMed]

244. Tokunaga C, Yoshino K, Yonezawa K. mTOR integrates amino acid- and energy-sensing pathways. Biochem. Biophys. Res. Commun. 2004;313:443–446. [PubMed]

245. Gonzalez NS, Communi D, Hannedouche S, Boeynaems JM. The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids. Purinergic Signal. 2004;1:17–20. [PMC free article] [PubMed]

246. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E, Peti-Peterdi J. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J. Clin. Invest. 2008;118:2526–2534. [PMC free article] [PubMed]

247. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O’Rahilly S, Schofield CJ. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318:1469–1472. [PMC free article] [PubMed]

248. Gillespie PG, Hudspeth AJ. Adenine nucleoside diphosphates block adaptation of mechanoelectrical transduction in hair cells. Proc. Natl. Acad. Sci. USA. 1993;90:2710–2714. [PubMed]

249. Mahajan VB, Pai KS, Lau A, Cunningham DD. Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. Proc. Natl. Acad. Sci. USA. 2000;97:12062–12067. [PubMed]

250. Kuiper JW, Pluk H, Oerlemans F, van Leeuwen FN, de Lange F, Fransen J, Wieringa B. Creatine kinase-mediated ATP supply fuels actin-based events in phagocytosis. PLoS Biol. 2008;6:E51. [PMC free article] [PubMed]

251. Bernstein BW, Bamburg JR. Actin-ATP hydrolysis is a major energy drain for neurons. J Neurosci. 2003;23:1–6. [PubMed]

252. Bridgman PC. Myosin-dependent transport in neurons. J. Neurobiol. 2004;58:164–174. [PubMed]

253. Aberg T, Ronquist G, Tyden H, Ahlund P, Bergstrom K. Release of adenylate kinase into cerebrospinal fluid during open-heart surgery and its relation to postoperative intellectual function. Lancet. 1982;1:1139–1142. [PubMed]

254. Toren A, Brok-Simoni F, Ben-Bassat I, Holtzman F, Mandel M, Neumann Y, Ramot B, Rechavi G, Kende G. Congenital haemolytic anaemia associated with adenylate kinase deficiency. Br. J. Haematol. 1994;87:376–380. [PubMed]

255. Shin JB, Streijger F, Beynon A, Peters T, Gadzala L, McMillen D, Bystrom C, van der Zee CE, Wallimann T, Gillespie PG. Hair bundles are specialized for ATP delivery via creatine kinase. Neuron. 2007;53:371–386. [PMC free article] [PubMed]

256. Yuan W, Yang J, Kopecková P, Kopecek J. Smart hydrogels containing adenylate kinase: translating substrate recognition into macroscopic motion. J. Am. Chem. Soc. 2008;130:15760–15761. [PubMed]

257. Kesimer M, Kirkham S, Pickles RJ, Henderson AG, Alexis NE, DeMaria G, Knight D, Thornton DJ, Sheehan JK. Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? Am. J. Physiol. 2009;296:L92–L100. [PMC free article] [PubMed]

258. Blackburn MR, RE Kellems RE. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv. Immunol. 2005;86:1–41. [PubMed]

259. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 2007;4:S60–S67. [PMC free article] [PubMed]

260. Chung S, Dzeja PP, Faustino RS, Terzic A. Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis. Ann. NY Acad. Sci. 2008;1147:254–263. [PMC free article] [PubMed]

261. Niethammer P, Kueh HY, Mitchison TJ. Spatial patterning of metabolism by mitochondria, oxygen, and energy sinks in a model cytoplasm. Curr. Biol. 2008;18:586–591. [PMC free article] [PubMed]

262. Miranda MR, Canepa GE, Bouvier LA, Pereira CA. Trypanosoma cruzi: multiple nucleoside diphosphate kinase isoforms in a single cell. Exp. Parasitol. 2008;120:103–107. [PubMed]

263. Thompson AA, Zou A, Yan J, Duggal R, Hao W, Molina D, Cronin CN, Wells PA. Biochemical characterization of recombinant hepatitis C virus nonstructural protein 4B: evidence for ATP/GTP hydrolysis and adenylate kinase activity. Biochemistry. 2009;48:906–916. [PubMed]

264. Rakkola R, Matikainen S, Nyman TA. Proteome characterization of human NK-92 cells identifies novel IFN-alpha and IL-15 target genes. J. Proteome Res. 2005;4:75–82. [PubMed]

265. Giroux V, Iovanna J, Dagorn JC. Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. FASEB J. 2006;20:1982–1991. [PubMed]

Articles from International Journal of Molecular Sciences are provided here courtesy of
Multidisciplinary Digital Publishing Institute (MDPI)